# ref_drug_names

standard_name: Abatacept
created_at: 2026-02-03 19:59:31
raw_name:
Orencia 125mg/1ml solution for injection pre-filled syringes (Bristol-Myers Squibb Pharmaceuticals Ltd)


standard_name: Abatacept
created_at: 2026-02-03 19:59:31
raw_name:
ORENCIA CLICKJECT 125MG/1ML SOLUTION FOR INJECTION PRE-FILLED PENS (BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD)


standard_name: ROMIPLOSTIM
created_at: 2026-02-03 19:59:31
raw_name:
ROMIPLOSTIM 250MICROGRAM POWDER AND SOLVENT FOR SOLUTION FOR INJECTION PRE-FILLED DISPOSABLE DEVICES


standard_name: misc
created_at: 2026-02-03 19:59:31
raw_name:
TRIOMEL 7G/LITRE NITROGEN 1140KCAL/LITRE WITH ELECTROLYTES INFUSION 2LITRE BAGS (BAXTER HEALTHCARE LTD)


# pathway_refresh_log

refresh_id: 0b2ec1bd
started_at: 2026-02-05T14:47:22.148965
completed_at: 2026-02-05T15:03:25.376188
status: completed
created_at: 2026-02-05 14:47:22
date_filter_counts:
{"all_6mo:directory": 293, "all_12mo:directory": 0, "1yr_6mo:directory": 0, "1yr_12mo:directory": 0, "2yr_6mo:directory": 0, "2yr_12mo:directory": 0, "all_6mo:indication": 0, "all_12mo:indication": 0, "1yr_6mo:indication": 0, "1yr_12mo:indication": 0, "2yr_6mo:indication": 0, "2yr_12mo:indication": 0}


refresh_id: 89b4d2a0
started_at: 2026-02-05T19:52:29.271070
completed_at: 2026-02-05T20:07:45.803994
status: completed
created_at: 2026-02-05 19:52:29
date_filter_counts:
{"all_6mo:directory": 293, "all_12mo:directory": 329, "1yr_6mo:directory": 93, "1yr_12mo:directory": 105, "2yr_6mo:directory": 134, "2yr_12mo:directory": 147, "all_6mo:indication": 695, "all_12mo:indication": 785, "1yr_6mo:indication": 167, "1yr_12mo:indication": 198, "2yr_6mo:indication": 315, "2yr_12mo:indication": 372}


refresh_id: a2c2398c
started_at: 2026-02-05T23:56:37.370814
completed_at: 2026-02-06T00:08:55.812828
status: completed
created_at: 2026-02-05 23:56:37
date_filter_counts:
{"all_6mo:directory": 293, "all_12mo:directory": 329, "1yr_6mo:directory": 93, "1yr_12mo:directory": 105, "2yr_6mo:directory": 134, "2yr_12mo:directory": 147, "all_6mo:indication": 438, "all_12mo:indication": 484, "1yr_6mo:indication": 181, "1yr_12mo:indication": 199, "2yr_6mo:indication": 257, "2yr_12mo:indication": 287}


# pathway_nodes

date_filter_id: all_6mo
chart_type: directory
labels: SECUKINUMAB
cost_pp_pa: 5399.24
first_seen: 2019-06-07T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-23
average_administered: [12.6, 11.8, 11.2, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.6 times with a 8.1 weekly interval (103.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 11.8 times with a 4.7 weekly interval (56.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 11.2 times with a 10.4 weekly interval (117.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 4557.96
first_seen: 2019-06-20T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-21
average_administered: [18.666666666666668, 14.833333333333334, 28.666666666666668, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 18.7 times with a 6.6 weekly interval (123.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 14.8 times with a 11.3 weekly interval (167.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 28.7 times with a 4.4 weekly interval (127.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - LUCENTIS - RANIBIZUMAB
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - LUCENTIS - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3821.21
first_seen: 2019-04-30T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-30
last_seen_parent: 2025-12-24
average_administered: [5.4, 18.2, 5.8, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: LUCENTIS|RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>LUCENTIS</b><br>On average given 5.4 times with a 23.9 weekly interval (129.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 18.2 times with a 5.7 weekly interval (104.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.8 times with a 7.3 weekly interval (42.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - DEXAMETHASONE
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - DEXAMETHASONE - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3293.84
first_seen: 2019-04-21T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-21
last_seen_parent: 2025-12-31
average_administered: [22.533333333333335, 2.7333333333333334, 5.666666666666667, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|DEXAMETHASONE|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22.5 times with a 10.7 weekly interval (241.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 2.7 times with a 18.4 weekly interval (50.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.7 times with a 3.9 weekly interval (22.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: RANIBIZUMAB
cost_pp_pa: 3257.03
first_seen: 2019-07-04T00:00:00
last_seen: 2025-12-20T00:00:00
first_seen_parent: 2019-07-04
last_seen_parent: 2025-12-20
average_administered: [21.333333333333332, 12.0, 2.8333333333333335, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.3 times with a 7.3 weekly interval (155.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 12.0 times with a 10.9 weekly interval (130.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 2.8 times with a 5.4 weekly interval (15.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 3274.97
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-30
average_administered: [17.25, 10.25, 6.25, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - RANIBIZUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 17.2 times with a 10.0 weekly interval (172.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 10.2 times with a 5.6 weekly interval (57.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.2 times with a 16.3 weekly interval (101.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 3482.76
first_seen: 2019-06-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-13
last_seen_parent: 2025-12-30
average_administered: [15.833333333333334, 11.5, 15.166666666666666, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB|RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB - RANIBIZUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 15.8 times with a 6.0 weekly interval (95.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 11.5 times with a 7.7 weekly interval (89.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 15.2 times with a 14.9 weekly interval (226.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 2920.48
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-26
average_administered: [15.333333333333334, 34.666666666666664, 12.333333333333334, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB - AFLIBERCEPT

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 15.3 times with a 29.4 weekly interval (450.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 34.7 times with a 3.0 weekly interval (104.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 12.3 times with a 9.0 weekly interval (111.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 2416.35
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-05-03
last_seen_parent: 2025-12-17
average_administered: [5.4, 11.2, 7.2, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.4 times with a 29.7 weekly interval (160.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 11.2 times with a 13.3 weekly interval (149.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 7.2 times with a 8.3 weekly interval (60.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: USTEKINUMAB
cost_pp_pa: N/A
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-22
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - INFLIXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - INFLIXIMAB - USTEKINUMAB


date_filter_id: all_6mo
chart_type: directory
labels: RITUXIMAB
cost_pp_pa: 2261.15
first_seen: 2019-04-29T00:00:00
last_seen: 2025-10-16T00:00:00
first_seen_parent: 2019-04-29
last_seen_parent: 2025-12-09
average_administered: [3.0, 10.666666666666666, 6.666666666666667, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB - RITUXIMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 3.0 times with a 18.1 weekly interval (54.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 10.7 times with a 3.6 weekly interval (38.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 6.7 times with a 30.6 weekly interval (205.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: SECUKINUMAB
cost_pp_pa: 4511.9
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-24
average_administered: [5.333333333333333, 19.333333333333332, 16.0, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 5.3 times with a 43.6 weekly interval (231.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 19.3 times with a 1.7 weekly interval (33.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 16.0 times with a 9.7 weekly interval (155.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: BEVACIZUMAB
cost_pp_pa: 4017.4
first_seen: 2020-02-07T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2020-02-07
last_seen_parent: 2025-12-27
average_administered: [19.8, 6.4, 16.4, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB - BEVACIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 19.8 times with a 7.1 weekly interval (141.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.4 times with a 24.3 weekly interval (155.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 16.4 times with a 4.0 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 4154.81
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-20T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-20
average_administered: [26.5, 12.0, 16.666666666666668, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 26.5 times with a 8.6 weekly interval (227.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 12.0 times with a 10.6 weekly interval (127.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 16.7 times with a 6.7 weekly interval (112.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: USTEKINUMAB
cost_pp_pa: 6882.83
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-29
average_administered: [5.75, 9.375, 16.0, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB - USTEKINUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.8 times with a 4.1 weekly interval (24.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 9.4 times with a 7.4 weekly interval (70.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 16.0 times with a 10.1 weekly interval (162.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: TOCILIZUMAB
cost_pp_pa: 4909.26
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [10.333333333333334, 2.3333333333333335, 16.333333333333332, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB - TOCILIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.3 times with a 11.0 weekly interval (113.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 2.3 times with a 4.3 weekly interval (10.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 16.3 times with a 6.0 weekly interval (98.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: UPADACITINIB
cost_pp_pa: 4983.39
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-18
average_administered: [8.5, 9.5, 16.5, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - SECUKINUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - SECUKINUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.5 times with a 5.3 weekly interval (45.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 9.5 times with a 7.7 weekly interval (73.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 16.5 times with a 6.3 weekly interval (104.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: ABATACEPT
cost_pp_pa: 4668.68
first_seen: 2019-05-21T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [21.0, 13.333333333333334, 2.0, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB|ABATACEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB - ABATACEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21.0 times with a 4.9 weekly interval (102.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 13.3 times with a 0.4 weekly interval (6.0 weeks total treatment length)<br><b>ABATACEPT</b><br>On average given 2.0 times with a 81.7 weekly interval (163.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: UPADACITINIB
cost_pp_pa: 5637.07
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-31
average_administered: [4.75, 5.5, 13.25, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.8 times with a 5.3 weekly interval (25.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 5.5 times with a 25.1 weekly interval (138.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 13.2 times with a 12.6 weekly interval (166.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: VEDOLIZUMAB
cost_pp_pa: 9758.58
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-31
average_administered: [9.0, 6.0, 24.0, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB - VEDOLIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.0 times with a 16.6 weekly interval (149.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 6.0 times with a 9.6 weekly interval (57.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 24.0 times with a 7.7 weekly interval (185.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: INFLIXIMAB
cost_pp_pa: 4530.1
first_seen: 2021-08-05T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2020-02-21
last_seen_parent: 2025-12-29
average_administered: [2.6666666666666665, 5.333333333333333, 11.0, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.7 times with a 5.3 weekly interval (14.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 5.3 times with a 4.7 weekly interval (25.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 11.0 times with a 6.6 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: RITUXIMAB
cost_pp_pa: 2761.33
first_seen: 2019-04-17T00:00:00
last_seen: 2025-10-31T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-30
average_administered: [16.333333333333332, 6.0, 3.0, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT - RITUXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16.3 times with a 7.3 weekly interval (119.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 6.0 times with a 3.9 weekly interval (23.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 3.0 times with a 10.0 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 4026.41
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-31
average_administered: [17.22222222222222, 10.5, 10.333333333333334, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 17.2 times with a 16.4 weekly interval (283.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 10.5 times with a 16.4 weekly interval (172.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 10.3 times with a 8.4 weekly interval (87.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ETANERCEPT
cost_pp_pa: 4589.83
first_seen: 2020-01-08T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-09-20
last_seen_parent: 2025-11-27
average_administered: [5.666666666666667, 16.333333333333332, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.7 times with a 7.1 weekly interval (41.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 16.3 times with a 6.0 weekly interval (98.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: AFLIBERCEPT
cost_pp_pa: 3663.15
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [17.725806451612904, 16.85483870967742, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 17.7 times with a 12.4 weekly interval (220.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 16.9 times with a 15.4 weekly interval (261.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: BEVACIZUMAB
cost_pp_pa: 3540.91
first_seen: 2019-07-09T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-05-22
last_seen_parent: 2025-12-18
average_administered: [1.5, 11.333333333333334, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - BEVACIZUMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 1.5 times with a 78.0 weekly interval (117.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 11.3 times with a 0.4 weekly interval (5.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: DEXAMETHASONE
cost_pp_pa: 2430.58
first_seen: 2019-05-22T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-04
last_seen_parent: 2025-12-31
average_administered: [4.0, 11.666666666666666, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - DEXAMETHASONE

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.0 times with a 58.0 weekly interval (232.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 11.7 times with a 14.0 weekly interval (164.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 3121.58
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [8.083044982698961, 15.771626297577855, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.1 times with a 32.1 weekly interval (260.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 15.8 times with a 5.9 weekly interval (93.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: RITUXIMAB
cost_pp_pa: 1121.34
first_seen: 2020-12-07T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2020-12-07
last_seen_parent: 2025-12-23
average_administered: [3.2, 8.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - RITUXIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.2 times with a 6.9 weekly interval (22.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 8.6 times with a 1.4 weekly interval (12.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: BARICITINIB
cost_pp_pa: 4093.33
first_seen: 2019-05-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [5.4, 17.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - BARICITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.4 times with a 9.7 weekly interval (52.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 17.6 times with a 13.4 weekly interval (236.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 5706.96
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-31
average_administered: [14.3, 17.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.3 times with a 8.4 weekly interval (121.0 weeks total treatment length)<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 17.6 times with a 8.9 weekly interval (156.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ETANERCEPT
cost_pp_pa: 3193.41
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [10.387755102040817, 16.051020408163264, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.4 times with a 8.9 weekly interval (92.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 16.1 times with a 5.9 weekly interval (94.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: INFLIXIMAB
cost_pp_pa: 2661.1
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [14.818181818181818, 17.636363636363637, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.8 times with a 9.1 weekly interval (135.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 17.6 times with a 6.4 weekly interval (113.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: IXEKIZUMAB
cost_pp_pa: 4543.8
first_seen: 2019-05-13T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-05-13
last_seen_parent: 2025-12-30
average_administered: [13.545454545454545, 14.636363636363637, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - IXEKIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.5 times with a 7.9 weekly interval (106.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 14.6 times with a 7.6 weekly interval (111.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: BEVACIZUMAB
cost_pp_pa: 1311.54
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-30
average_administered: [7.0, 2.75, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 7.0 times with a 17.9 weekly interval (125.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 2.8 times with a 15.3 weekly interval (43.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 3209.43
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-24
average_administered: [14.311688311688311, 8.311688311688311, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14.3 times with a 11.7 weekly interval (168.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 8.3 times with a 7.0 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: RANIBIZUMAB
cost_pp_pa: 2630.2
first_seen: 2019-05-04T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2019-05-04
last_seen_parent: 2025-12-23
average_administered: [25.571428571428573, 4.142857142857143, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 25.6 times with a 11.4 weekly interval (293.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 4.1 times with a 4.0 weekly interval (16.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: UPADACITINIB
cost_pp_pa: 11972.59
first_seen: 2019-04-29T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-29
last_seen_parent: 2025-12-30
average_administered: [9.6, 22.4, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - USTEKINUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - USTEKINUMAB - UPADACITINIB

average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9.6 times with a 7.9 weekly interval (75.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 22.4 times with a 4.6 weekly interval (102.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: TOFACITINIB
cost_pp_pa: 7547.82
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-23
average_administered: [3.75, 21.625, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - TOFACITINIB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.8 times with a 4.9 weekly interval (18.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 21.6 times with a 7.3 weekly interval (157.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: UPADACITINIB
cost_pp_pa: 5234.82
first_seen: 2020-05-26T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2020-05-26
last_seen_parent: 2025-12-23
average_administered: [6.888888888888889, 8.555555555555555, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - UPADACITINIB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.9 times with a 5.1 weekly interval (35.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 8.6 times with a 7.7 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: VEDOLIZUMAB
cost_pp_pa: 9016.94
first_seen: 2019-04-25T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2019-04-25
last_seen_parent: 2025-12-19
average_administered: [9.0, 21.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - VEDOLIZUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9.0 times with a 4.1 weekly interval (37.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 21.0 times with a 6.3 weekly interval (132.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: ADALIMUMAB
cost_pp_pa: 3211.14
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-30
average_administered: [21.903225806451612, 8.580645161290322, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21.9 times with a 7.7 weekly interval (169.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 8.6 times with a 46.4 weekly interval (399.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2631.33
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-29
average_administered: [38.285714285714285, 10.428571428571429, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RANIBIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 38.3 times with a 8.1 weekly interval (312.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 10.4 times with a 7.3 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: RITUXIMAB
cost_pp_pa: 3001.7
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [10.88888888888889, 7.388888888888889, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.9 times with a 8.0 weekly interval (87.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 7.4 times with a 17.4 weekly interval (129.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: SECUKINUMAB
cost_pp_pa: 4663.17
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [9.565217391304348, 20.73913043478261, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.6 times with a 7.3 weekly interval (70.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 20.7 times with a 9.6 weekly interval (198.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: UPADACITINIB
cost_pp_pa: 3276.45
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-09
average_administered: [17.4, 11.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17.4 times with a 7.7 weekly interval (134.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 11.6 times with a 7.7 weekly interval (89.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 6581.05
first_seen: 2019-04-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-20
last_seen_parent: 2025-12-29
average_administered: [21.666666666666668, 17.333333333333332, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 21.7 times with a 21.3 weekly interval (462.0 weeks total treatment length)<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 17.3 times with a 36.6 weekly interval (633.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: RITUXIMAB
cost_pp_pa: 3201.31
first_seen: 2019-04-08T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-30
average_administered: [20.666666666666668, 3.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - RITUXIMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 20.7 times with a 7.7 weekly interval (160.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 3.5 times with a 11.1 weekly interval (39.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: SECUKINUMAB
cost_pp_pa: 5319.25
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-23
average_administered: [9.6, 29.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - SECUKINUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9.6 times with a 8.0 weekly interval (77.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 29.6 times with a 8.9 weekly interval (262.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ADALIMUMAB
cost_pp_pa: 2801.46
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [19.489795918367346, 19.46938775510204, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19.5 times with a 13.7 weekly interval (267.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 19.5 times with a 25.4 weekly interval (496.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: INFLIXIMAB
cost_pp_pa: 3582.12
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-30
average_administered: [14.333333333333334, 20.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.3 times with a 7.6 weekly interval (108.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 20.5 times with a 6.9 weekly interval (141.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: RISANKIZUMAB
cost_pp_pa: 4885.04
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-22
average_administered: [23.8, 7.4, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - RISANKIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23.8 times with a 7.9 weekly interval (187.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 7.4 times with a 5.6 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: TOFACITINIB
cost_pp_pa: 5598.16
first_seen: 2019-04-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-07
last_seen_parent: 2025-12-29
average_administered: [8.1875, 28.0625, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - TOFACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.2 times with a 7.3 weekly interval (60.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 28.1 times with a 8.1 weekly interval (229.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: UPADACITINIB
cost_pp_pa: 4784.83
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-22
average_administered: [13.235294117647058, 9.764705882352942, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.2 times with a 7.1 weekly interval (94.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 9.8 times with a 7.7 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: VEDOLIZUMAB
cost_pp_pa: 7188.05
first_seen: 2019-05-14T00:00:00
last_seen: 2025-12-04T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-04
average_administered: [13.0, 11.571428571428571, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - VEDOLIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.0 times with a 8.1 weekly interval (106.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 11.6 times with a 5.6 weekly interval (65.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: IXEKIZUMAB
cost_pp_pa: 6634.48
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-11-25
average_administered: [14.0, 12.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - SECUKINUMAB - IXEKIZUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 14.0 times with a 19.6 weekly interval (274.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 12.5 times with a 21.1 weekly interval (264.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: BARICITINIB
cost_pp_pa: 5141.37
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-15
average_administered: [21.25, 21.25, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB - BARICITINIB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 21.2 times with a 3.9 weekly interval (82.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 21.2 times with a 41.0 weekly interval (869.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: ABATACEPT
cost_pp_pa: 3803.37
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-30
average_administered: [26.571428571428573, 6.285714285714286, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|ABATACEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB - ABATACEPT

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 26.6 times with a 25.9 weekly interval (688.0 weeks total treatment length)<br><b>ABATACEPT</b><br>On average given 6.3 times with a 27.6 weekly interval (174.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: USTEKINUMAB
cost_pp_pa: 3073.04
first_seen: 2019-06-27T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2019-06-27
last_seen_parent: 2025-12-19
average_administered: [6.0, 5.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB - USTEKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.0 times with a 11.7 weekly interval (70.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 5.0 times with a 14.1 weekly interval (71.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST
labels: ADALIMUMAB
cost_pp_pa: 4725.43
first_seen: 2019-12-05T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-10-04
last_seen_parent: 2025-12-23
average_administered: [11.5, 10.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: APREMILAST|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST - ADALIMUMAB

average_spacing:
<br><b>APREMILAST</b><br>On average given 11.5 times with a 7.6 weekly interval (87.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 10.0 times with a 12.4 weekly interval (124.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST
labels: ADALIMUMAB
cost_pp_pa: 4567.15
first_seen: 2022-04-04T00:00:00
last_seen: 2025-12-01T00:00:00
first_seen_parent: 2019-05-13
last_seen_parent: 2025-12-22
average_administered: [10.25, 4.75, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: APREMILAST|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST - ADALIMUMAB

average_spacing:
<br><b>APREMILAST</b><br>On average given 10.2 times with a 3.9 weekly interval (39.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 4.8 times with a 24.7 weekly interval (119.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 6541.34
first_seen: 2019-04-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-12-31
average_administered: [7.785714285714286, 6.428571428571429, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.8 times with a 6.4 weekly interval (50.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 6.4 times with a 12.0 weekly interval (77.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 2038.09
first_seen: 2023-02-27T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2023-02-27
last_seen_parent: 2025-12-19
average_administered: [7.25, 2.375, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.2 times with a 10.3 weekly interval (74.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 2.4 times with a 7.9 weekly interval (19.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: INFLIXIMAB
cost_pp_pa: 4366.3
first_seen: 2019-08-15T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-08-15
last_seen_parent: 2025-12-22
average_administered: [5.166666666666667, 16.666666666666668, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.2 times with a 11.1 weekly interval (58.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 16.7 times with a 5.7 weekly interval (95.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: USTEKINUMAB
cost_pp_pa: 6531.21
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-31
average_administered: [14.384615384615385, 17.76923076923077, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.4 times with a 12.3 weekly interval (177.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 17.8 times with a 9.9 weekly interval (175.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2421.74
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-29
average_administered: [9.692307692307692, 6.230769230769231, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9.7 times with a 5.7 weekly interval (55.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 6.2 times with a 11.3 weekly interval (70.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 7256.87
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-30
average_administered: [10.0, 11.1, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10.0 times with a 4.6 weekly interval (46.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 11.1 times with a 8.1 weekly interval (90.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 10818.88
first_seen: 2020-05-27T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-05-27
last_seen_parent: 2025-12-31
average_administered: [7.142857142857143, 15.428571428571429, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.1 times with a 4.7 weekly interval (33.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 15.4 times with a 5.4 weekly interval (84.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4801.54
first_seen: 2021-05-24T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-05-29
last_seen_parent: 2025-12-31
average_administered: [10.4, 7.2, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.4 times with a 13.1 weekly interval (137.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 7.2 times with a 4.4 weekly interval (32.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 6990.54
first_seen: 2021-11-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-05-03
last_seen_parent: 2025-12-31
average_administered: [14.166666666666666, 2.8333333333333335, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.2 times with a 9.3 weekly interval (132.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 2.8 times with a 7.3 weekly interval (20.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 11825.52
first_seen: 2021-01-19T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2021-01-19
last_seen_parent: 2025-12-31
average_administered: [3.4, 21.4, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.4 times with a 6.7 weekly interval (23.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 21.4 times with a 6.3 weekly interval (135.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - USTEKINUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - USTEKINUMAB - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 8519.39
first_seen: 2019-04-18T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-12-23
average_administered: [11.0, 12.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 11.0 times with a 83.9 weekly interval (922.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 12.0 times with a 35.3 weekly interval (423.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: ADALIMUMAB
cost_pp_pa: 4866.74
first_seen: 2019-06-08T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-29
average_administered: [14.875, 9.6875, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14.9 times with a 20.6 weekly interval (307.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 9.7 times with a 25.9 weekly interval (251.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: USTEKINUMAB
cost_pp_pa: 4177.6
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-23
average_administered: [21.3, 6.6, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - USTEKINUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21.3 times with a 8.1 weekly interval (173.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 6.6 times with a 8.9 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: USTEKINUMAB
cost_pp_pa: N/A
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-29
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - USTEKINUMAB


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - GOLIMUMAB
labels: GALCANEZUMAB
cost_pp_pa: 2375.77
first_seen: 2022-03-10T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2022-03-10
last_seen_parent: 2025-09-25
average_administered: [9.666666666666666, 6.166666666666667, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: GOLIMUMAB|GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - GOLIMUMAB - GALCANEZUMAB

average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 9.7 times with a 5.6 weekly interval (54.0 weeks total treatment length)<br><b>GALCANEZUMAB</b><br>On average given 6.2 times with a 48.0 weekly interval (298.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: SECUKINUMAB
cost_pp_pa: 6486.31
first_seen: 2019-04-24T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-24
last_seen_parent: 2025-12-29
average_administered: [8.333333333333334, 13.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.3 times with a 8.1 weekly interval (68.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 13.5 times with a 13.3 weekly interval (179.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1828.93
first_seen: 2019-08-29T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-08-29
last_seen_parent: 2025-12-30
average_administered: [13.2, 2.8, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13.2 times with a 9.0 weekly interval (119.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 2.8 times with a 5.9 weekly interval (16.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 3221.09
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-21
last_seen_parent: 2025-12-31
average_administered: [21.375, 3.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.4 times with a 8.9 weekly interval (190.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 3.5 times with a 19.1 weekly interval (67.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2898.57
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [21.84285714285714, 6.0285714285714285, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.8 times with a 9.4 weekly interval (206.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.0 times with a 5.0 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - BOTULINUM A TOXIN
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - BOTULINUM A TOXIN - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 1826.07
first_seen: 2019-04-25T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-25
last_seen_parent: 2025-12-29
average_administered: [3.3846153846153846, 30.615384615384617, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY
drug_sequence: BOTULINUM A TOXIN|FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BOTULINUM A TOXIN</b><br>On average given 3.4 times with a 10.1 weekly interval (34.0 weeks total treatment length)<br><b>FREMANEZUMAB</b><br>On average given 30.6 times with a 7.3 weekly interval (223.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 1857.07
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-18
average_administered: [5.642857142857143, 17.285714285714285, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5.6 times with a 49.7 weekly interval (278.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 17.3 times with a 6.3 weekly interval (109.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2170.33
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-22
average_administered: [10.615384615384615, 14.538461538461538, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 10.6 times with a 21.6 weekly interval (229.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 14.5 times with a 18.7 weekly interval (271.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 2068.93
first_seen: 2019-05-03T00:00:00
last_seen: 2025-08-27T00:00:00
first_seen_parent: 2019-04-17
last_seen_parent: 2025-12-08
average_administered: [5.0, 13.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5.0 times with a 53.3 weekly interval (266.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 13.0 times with a 8.7 weekly interval (113.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: FARICIMAB
cost_pp_pa: 1430.56
first_seen: 2019-06-13T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-13
last_seen_parent: 2025-12-30
average_administered: [21.0, 10.181818181818182, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB - FARICIMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 21.0 times with a 6.1 weekly interval (129.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 10.2 times with a 6.6 weekly interval (67.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1615.89
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-30
average_administered: [20.357142857142858, 9.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB - RANIBIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20.4 times with a 9.0 weekly interval (184.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 9.0 times with a 10.1 weekly interval (91.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE
labels: RANIBIZUMAB
cost_pp_pa: 1307.62
first_seen: 2021-01-25T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-01-25
last_seen_parent: 2025-12-30
average_administered: [1.25, 6.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE - RANIBIZUMAB

average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.2 times with a 62.1 weekly interval (75.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 6.0 times with a 9.7 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: BEVACIZUMAB
cost_pp_pa: 2884.44
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [22.96875, 17.46875, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23.0 times with a 10.9 weekly interval (250.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 17.5 times with a 11.0 weekly interval (192.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: DEXAMETHASONE
cost_pp_pa: 2847.3
first_seen: 2019-06-20T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-06-20
last_seen_parent: 2025-12-30
average_administered: [18.166666666666668, 2.5, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - DEXAMETHASONE

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18.2 times with a 8.7 weekly interval (159.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 2.5 times with a 20.0 weekly interval (50.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 4203.08
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-30
average_administered: [21.256880733944953, 12.20183486238532, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.3 times with a 7.7 weekly interval (164.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 12.2 times with a 7.7 weekly interval (94.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: RANIBIZUMAB
cost_pp_pa: 2239.7
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [13.892857142857142, 6.071428571428571, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13.9 times with a 10.4 weekly interval (145.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 6.1 times with a 8.4 weekly interval (51.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 2172.61
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-26
average_administered: [17.0, 27.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 17.0 times with a 20.7 weekly interval (352.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 27.0 times with a 38.9 weekly interval (1049.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - CERTOLIZUMAB PEGOL
labels: ADALIMUMAB
cost_pp_pa: 5634.75
first_seen: 2019-07-15T00:00:00
last_seen: 2025-10-30T00:00:00
first_seen_parent: 2019-07-15
last_seen_parent: 2025-12-19
average_administered: [13.75, 22.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - CERTOLIZUMAB PEGOL - ADALIMUMAB

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 13.8 times with a 74.1 weekly interval (1023.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 22.0 times with a 50.1 weekly interval (1103.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ADALIMUMAB
cost_pp_pa: 3382.7
first_seen: 2019-06-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-06
last_seen_parent: 2025-12-30
average_administered: [11.615384615384615, 19.692307692307693, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11.6 times with a 21.4 weekly interval (249.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 19.7 times with a 22.3 weekly interval (439.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - IXEKIZUMAB
labels: IXEKIZUMAB
cost_pp_pa: 5685.87
first_seen: 2020-12-01T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2020-12-01
last_seen_parent: 2025-12-17
average_administered: [7.857142857142857, 7.214285714285714, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.9 times with a 7.6 weekly interval (60.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 7.2 times with a 10.0 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1464.88
first_seen: 2021-02-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2021-02-04
last_seen_parent: 2025-12-29
average_administered: [6.5, 4.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.5 times with a 8.0 weekly interval (52.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4.0 times with a 7.6 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 4432.01
first_seen: 2019-07-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-07-01
last_seen_parent: 2025-12-29
average_administered: [10.181818181818182, 20.181818181818183, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.2 times with a 6.9 weekly interval (70.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 20.2 times with a 6.7 weekly interval (136.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 3081.4
first_seen: 2019-05-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-02
last_seen_parent: 2025-12-31
average_administered: [6.333333333333333, 3.8333333333333335, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.3 times with a 7.1 weekly interval (45.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 3.8 times with a 9.0 weekly interval (34.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 2409.15
first_seen: 2023-01-16T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2023-01-16
last_seen_parent: 2025-12-08
average_administered: [4.333333333333333, 3.6666666666666665, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.3 times with a 12.6 weekly interval (54.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 3.7 times with a 6.7 weekly interval (25.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - CERTOLIZUMAB PEGOL
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - CERTOLIZUMAB PEGOL - IXEKIZUMAB
labels: IXEKIZUMAB
cost_pp_pa: 6496.25
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-04-05
last_seen_parent: 2025-12-08
average_administered: [26.75, 7.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 26.8 times with a 9.4 weekly interval (253.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 7.0 times with a 13.7 weekly interval (96.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ETANERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 4824.25
first_seen: 2024-06-06T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-04-10
last_seen_parent: 2025-12-16
average_administered: [3.5, 3.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 3.5 times with a 8.9 weekly interval (31.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 3.5 times with a 19.4 weekly interval (68.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: RITUXIMAB
cost_pp_pa: 1687.89
first_seen: 2019-07-12T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-07-12
last_seen_parent: 2025-12-31
average_administered: [10.25, 11.25, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - RITUXIMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10.2 times with a 5.6 weekly interval (57.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 11.2 times with a 16.1 weekly interval (181.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: DEXAMETHASONE
cost_pp_pa: 4554.77
first_seen: 2023-02-26T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-21
average_administered: [1.8888888888888888, 7.111111111111111, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - DEXAMETHASONE

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 1.9 times with a 8.7 weekly interval (17.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 7.1 times with a 17.3 weekly interval (123.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 3825.47
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [9.508771929824562, 14.31578947368421, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9.5 times with a 15.6 weekly interval (148.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 14.3 times with a 10.9 weekly interval (155.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 6865.4
first_seen: 2019-06-25T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-21
average_administered: [6.666666666666667, 7.083333333333333, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.7 times with a 5.7 weekly interval (38.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 7.1 times with a 10.3 weekly interval (73.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 2288.11
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-30
average_administered: [9.45, 14.85, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - BEVACIZUMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9.4 times with a 32.6 weekly interval (306.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 14.8 times with a 14.3 weekly interval (211.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: RITUXIMAB
cost_pp_pa: 1232.97
first_seen: 2019-06-07T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-18
average_administered: [9.125, 6.875, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.1 times with a 9.4 weekly interval (86.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 6.9 times with a 15.1 weekly interval (104.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 5098.48
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [18.285714285714285, 13.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18.3 times with a 9.0 weekly interval (165.0 weeks total treatment length)<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 13.0 times with a 11.4 weekly interval (149.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ETANERCEPT
cost_pp_pa: 3373.82
first_seen: 2019-06-14T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-30
average_administered: [7.96, 12.44, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.0 times with a 8.0 weekly interval (64.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 12.4 times with a 7.3 weekly interval (90.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3384.35
first_seen: 2019-06-05T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-11-27
average_administered: [35.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 35.6 times with a 9.0 weekly interval (320.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3789.12
first_seen: 2019-06-18T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-18
last_seen_parent: 2025-11-27
average_administered: [31.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 31.5 times with a 6.3 weekly interval (198.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY - EVOLOCUMAB
labels: EVOLOCUMAB
cost_pp_pa: 2018.64
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-29
average_administered: [37.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ENDOCRINOLOGY
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 37.0 times with a 4.3 weekly interval (159.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY - OCTREOTIDE
labels: OCTREOTIDE
cost_pp_pa: 6347.99
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-11
average_administered: [11.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ENDOCRINOLOGY
drug_sequence: OCTREOTIDE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OCTREOTIDE</b><br>On average given 11.6 times with a 4.3 weekly interval (50.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: ADALIMUMAB
cost_pp_pa: 2852.2
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [31.3475935828877, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 31.3 times with a 8.3 weekly interval (259.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 9039.89
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [15.9, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 15.9 times with a 12.0 weekly interval (191.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 8565.55
first_seen: 2023-05-24T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-31
average_administered: [1.95, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.9 times with a 19.4 weekly interval (37.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5338.28
first_seen: 2023-04-18T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2023-04-18
last_seen_parent: 2025-12-30
average_administered: [5.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.6 times with a 6.0 weekly interval (34.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 3343.74
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [8.871980676328503, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.9 times with a 10.6 weekly interval (94.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 4903.52
first_seen: 2019-06-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-05-17
last_seen_parent: 2025-12-30
average_administered: [19.363636363636363, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19.4 times with a 12.6 weekly interval (244.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4986.03
first_seen: 2019-06-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-10
last_seen_parent: 2025-12-31
average_administered: [7.949367088607595, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.9 times with a 12.0 weekly interval (95.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2001.19
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-29
average_administered: [22.72, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22.7 times with a 9.4 weekly interval (214.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3352.56
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [22.440677966101696, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22.4 times with a 11.4 weekly interval (256.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1529.93
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-30
average_administered: [16.584415584415584, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 16.6 times with a 10.6 weekly interval (175.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4137.71
first_seen: 2022-12-23T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-12-23
last_seen_parent: 2025-12-29
average_administered: [8.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 8.0 times with a 8.6 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 4108.51
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-28
average_administered: [15.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15.7 times with a 13.9 weekly interval (218.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3966.64
first_seen: 2019-04-09T00:00:00
last_seen: 2025-11-04T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-11-04
average_administered: [25.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25.1 times with a 12.6 weekly interval (316.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2314.91
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-05
last_seen_parent: 2025-12-31
average_administered: [11.78, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.8 times with a 10.0 weekly interval (118.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3737.24
first_seen: 2019-06-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-31
average_administered: [31.333333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 31.3 times with a 6.7 weekly interval (210.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2093.94
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-31
average_administered: [13.714285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13.7 times with a 18.1 weekly interval (249.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 4383.31
first_seen: 2022-06-30T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-06-30
last_seen_parent: 2025-12-30
average_administered: [8.833333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 8.8 times with a 13.1 weekly interval (116.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8080.2
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-31
average_administered: [23.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23.5 times with a 12.4 weekly interval (292.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - ERENUMAB
labels: ERENUMAB
cost_pp_pa: 1728.7
first_seen: 2022-03-14T00:00:00
last_seen: 2025-11-24T00:00:00
first_seen_parent: 2022-03-14
last_seen_parent: 2025-11-24
average_administered: [18.666666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: ERENUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ERENUMAB</b><br>On average given 18.7 times with a 10.9 weekly interval (203.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - GOLIMUMAB
labels: GOLIMUMAB
cost_pp_pa: 8387.45
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [42.083333333333336, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 42.1 times with a 8.3 weekly interval (349.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3477.84
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-30
average_administered: [43.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 43.2 times with a 6.9 weekly interval (296.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - IXEKIZUMAB
labels: IXEKIZUMAB
cost_pp_pa: 9012.09
first_seen: 2023-05-11T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2023-05-11
last_seen_parent: 2025-12-19
average_administered: [9.714285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IXEKIZUMAB</b><br>On average given 9.7 times with a 12.3 weekly interval (119.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1470.61
first_seen: 2023-01-30T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2023-01-30
last_seen_parent: 2025-12-29
average_administered: [6.1875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6.2 times with a 10.1 weekly interval (63.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 5088.87
first_seen: 2019-07-11T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-07-11
last_seen_parent: 2025-12-23
average_administered: [24.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 24.4 times with a 10.1 weekly interval (247.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 10302.65
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-29
average_administered: [33.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 33.2 times with a 5.3 weekly interval (175.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4188.42
first_seen: 2023-11-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2023-11-03
last_seen_parent: 2025-12-31
average_administered: [6.0085470085470085, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 6.0 times with a 6.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 5071.8
first_seen: 2019-04-16T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-16
last_seen_parent: 2025-12-31
average_administered: [47.666666666666664, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 47.7 times with a 5.4 weekly interval (259.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2115.12
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [22.198237885462554, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22.2 times with a 9.4 weekly interval (209.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 5328.32
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-18
average_administered: [59.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 59.2 times with a 5.3 weekly interval (313.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - CERTOLIZUMAB PEGOL
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 7920.06
first_seen: 2019-07-12T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-24
average_administered: [37.733333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 37.7 times with a 8.7 weekly interval (329.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3626.31
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-31
average_administered: [31.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 31.0 times with a 8.1 weekly interval (252.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - FILGOTINIB
labels: FILGOTINIB
cost_pp_pa: 3080.72
first_seen: 2022-03-25T00:00:00
last_seen: 2025-09-21T00:00:00
first_seen_parent: 2021-10-25
last_seen_parent: 2025-12-22
average_administered: [7.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 7.0 times with a 30.3 weekly interval (212.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2731.8
first_seen: 2021-03-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-12-30
average_administered: [10.80952380952381, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.8 times with a 10.1 weekly interval (110.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2833.75
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [17.461682242990655, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 17.5 times with a 11.7 weekly interval (205.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 943.73
first_seen: 2021-03-16T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2021-03-16
last_seen_parent: 2025-12-18
average_administered: [3.111111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 3.1 times with a 21.0 weekly interval (65.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 2200.7
first_seen: 2019-08-22T00:00:00
last_seen: 2025-11-19T00:00:00
first_seen_parent: 2019-08-22
last_seen_parent: 2025-12-18
average_administered: [5.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 5.3 times with a 52.4 weekly interval (278.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 7775.45
first_seen: 2019-06-10T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-19
average_administered: [23.285714285714285, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 23.3 times with a 10.9 weekly interval (253.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 8813.8
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-31
average_administered: [176.21428571428572, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 176.2 times with a 2.0 weekly interval (352.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 8727.75
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [4.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.9 times with a 4.4 weekly interval (22.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1387.16
first_seen: 2025-01-22T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-29
average_administered: [4.416666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.4 times with a 2.9 weekly interval (13.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2642.11
first_seen: 2021-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-02-12
last_seen_parent: 2025-12-30
average_administered: [16.666666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 16.7 times with a 9.1 weekly interval (153.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - GALCANEZUMAB
labels: GALCANEZUMAB
cost_pp_pa: 2820.2
first_seen: 2022-01-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2022-01-17
last_seen_parent: 2025-12-31
average_administered: [17.615384615384617, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY
drug_sequence: GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GALCANEZUMAB</b><br>On average given 17.6 times with a 7.9 weekly interval (138.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY
labels: ALIROCUMAB
cost_pp_pa: 2230.03
first_seen: 2021-01-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-01-11
last_seen_parent: 2025-12-30
average_administered: [15.736842105263158, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY
drug_sequence: ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY - ALIROCUMAB

average_spacing:
<br><b>ALIROCUMAB</b><br>On average given 15.7 times with a 7.1 weekly interval (112.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4459.86
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [23.67105263157895, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 23.7 times with a 6.0 weekly interval (142.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8884.82
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-30
average_administered: [18.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18.0 times with a 9.6 weekly interval (172.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 13014.56
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [21.482758620689655, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 21.5 times with a 6.7 weekly interval (144.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 22644.67
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-18
average_administered: [17.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 17.1 times with a 3.0 weekly interval (51.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 7436.05
first_seen: 2024-10-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-10-29
last_seen_parent: 2025-12-31
average_administered: [11.833333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11.8 times with a 2.6 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 20499.81
first_seen: 2022-12-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-12-06
last_seen_parent: 2025-12-30
average_administered: [11.595744680851064, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 11.6 times with a 3.4 weekly interval (40.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 2757.6
first_seen: 2021-06-16T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-06-16
last_seen_parent: 2025-12-30
average_administered: [16.444444444444443, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 16.4 times with a 2.7 weekly interval (45.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 292.6
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-29
average_administered: [6.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 6.9 times with a 2.0 weekly interval (14.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2436.1
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [8.423076923076923, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8.4 times with a 28.4 weekly interval (239.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 5790.97
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-29
average_administered: [28.941176470588236, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28.9 times with a 8.9 weekly interval (256.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 8427.49
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [47.36842105263158, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 47.4 times with a 5.1 weekly interval (244.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: 4993.61
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-11
average_administered: [26.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 26.0 times with a 6.9 weekly interval (178.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: UPADACITINIB
cost_pp_pa: 3820.3
first_seen: 2022-03-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-03-04
last_seen_parent: 2025-12-29
average_administered: [25.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 25.8 times with a 7.4 weekly interval (192.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - APREMILAST
labels: APREMILAST
cost_pp_pa: 4596.81
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [24.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 24.5 times with a 12.3 weekly interval (301.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 4870.93
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [19.80952380952381, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19.8 times with a 12.4 weekly interval (246.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 8531.12
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [24.07894736842105, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 24.1 times with a 9.9 weekly interval (238.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3650.65
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [36.77929155313352, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 36.8 times with a 8.6 weekly interval (315.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - FILGOTINIB
labels: FILGOTINIB
cost_pp_pa: 5042.22
first_seen: 2023-01-18T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2022-11-09
last_seen_parent: 2025-12-30
average_administered: [7.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 7.3 times with a 3.3 weekly interval (24.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - GOLIMUMAB
labels: GOLIMUMAB
cost_pp_pa: 8307.0
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [34.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 34.0 times with a 9.4 weekly interval (321.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: IMMUNOGLOBULIN
cost_pp_pa: 33245.25
first_seen: 2024-04-04T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2021-04-23
last_seen_parent: 2025-12-11
average_administered: [23.636363636363637, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 23.6 times with a 2.4 weekly interval (57.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 2808.37
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [33.84415584415584, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 33.8 times with a 7.6 weekly interval (256.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2079.85
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [27.965041398344066, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28.0 times with a 8.6 weekly interval (240.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 8857.29
first_seen: 2020-04-08T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2020-02-27
last_seen_parent: 2025-12-18
average_administered: [11.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 11.0 times with a 9.6 weekly interval (105.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4464.49
first_seen: 2019-04-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [19.833333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 19.8 times with a 21.0 weekly interval (416.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 8295.89
first_seen: 2019-07-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-07-01
last_seen_parent: 2025-12-29
average_administered: [18.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 18.4 times with a 12.4 weekly interval (229.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 7121.06
first_seen: 2023-01-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2023-01-03
last_seen_parent: 2025-12-31
average_administered: [8.052631578947368, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 8.1 times with a 8.9 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3619.18
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-31
average_administered: [28.54054054054054, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28.5 times with a 8.9 weekly interval (252.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4812.16
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-31
average_administered: [17.20979020979021, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 17.2 times with a 6.1 weekly interval (106.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 10820.66
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-31
average_administered: [25.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25.5 times with a 9.4 weekly interval (240.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3100.19
first_seen: 2020-01-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-12-31
average_administered: [9.831460674157304, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.8 times with a 9.3 weekly interval (91.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - APREMILAST
labels: APREMILAST
cost_pp_pa: 4830.11
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-01
last_seen_parent: 2025-12-31
average_administered: [22.285714285714285, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 22.3 times with a 11.7 weekly interval (261.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY
labels: IMMUNOGLOBULIN
cost_pp_pa: 35057.52
first_seen: 2024-04-10T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2024-04-10
last_seen_parent: 2025-09-24
average_administered: [38.333333333333336, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 38.3 times with a 2.3 weekly interval (88.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3636.12
first_seen: 2019-04-17T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-17
last_seen_parent: 2025-12-31
average_administered: [12.451219512195122, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.5 times with a 9.1 weekly interval (114.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2884.2
first_seen: 2023-12-12T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2023-01-24
last_seen_parent: 2025-09-26
average_administered: [4.111111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 4.1 times with a 20.6 weekly interval (84.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY
labels: EVOLOCUMAB
cost_pp_pa: 1907.14
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [46.62068965517241, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY - EVOLOCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 46.6 times with a 4.9 weekly interval (226.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: ACALABRUTINIB
cost_pp_pa: 30157.02
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-29
average_administered: [18.568627450980394, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 18.6 times with a 4.3 weekly interval (80.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: IMMUNOGLOBULIN
cost_pp_pa: 20727.97
first_seen: 2024-04-05T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2024-04-05
last_seen_parent: 2025-09-26
average_administered: [21.51851851851852, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 21.5 times with a 3.0 weekly interval (64.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: OBINUTUZUMAB
cost_pp_pa: 33166.45
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-31
average_administered: [8.615384615384615, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: OBINUTUZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - OBINUTUZUMAB

average_spacing:
<br><b>OBINUTUZUMAB</b><br>On average given 8.6 times with a 2.7 weekly interval (23.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: RITUXIMAB
cost_pp_pa: 5998.29
first_seen: 2020-08-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-08-06
last_seen_parent: 2025-12-31
average_administered: [11.031055900621118, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.0 times with a 3.1 weekly interval (35.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORTH WEST ANGLIA NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORTH WEST ANGLIA NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 5107.67
first_seen: 2021-02-19T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2019-08-12
last_seen_parent: 2025-12-18
average_administered: [26.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORTH WEST ANGLIA NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26.5 times with a 7.7 weekly interval (204.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1363.56
first_seen: 2025-05-30T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-05-30
last_seen_parent: 2025-12-31
average_administered: [3.2222222222222223, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: BREAST SURGERY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.2 times with a 2.4 weekly interval (8.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY - ACALABRUTINIB
labels: ACALABRUTINIB
cost_pp_pa: 28775.43
first_seen: 2024-05-01T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-05-01
last_seen_parent: 2025-12-19
average_administered: [13.818181818181818, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 13.8 times with a 5.0 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8416.22
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-24
average_administered: [26.555555555555557, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 26.6 times with a 12.4 weekly interval (331.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST
labels: APREMILAST
cost_pp_pa: 5266.13
first_seen: 2020-07-05T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-09-19
last_seen_parent: 2025-12-23
average_administered: [18.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 18.0 times with a 12.3 weekly interval (221.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DIMETHYL FUMARATE
labels: DIMETHYL FUMARATE
cost_pp_pa: 242562.79
first_seen: 2025-10-17T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2019-06-08
last_seen_parent: 2025-12-23
average_administered: [2.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 2.5 times with a 1.3 weekly interval (3.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7639.53
first_seen: 2019-09-18T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-09-18
last_seen_parent: 2025-12-29
average_administered: [10.9375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 10.9 times with a 8.9 weekly interval (97.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4384.55
first_seen: 2019-06-14T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-24
average_administered: [33.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 33.0 times with a 9.7 weekly interval (321.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8052.71
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-29
average_administered: [23.674418604651162, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23.7 times with a 12.4 weekly interval (295.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 11185.07
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-31
average_administered: [34.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 34.2 times with a 7.1 weekly interval (244.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: ACALABRUTINIB
cost_pp_pa: 24242.84
first_seen: 2021-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-04-02
last_seen_parent: 2025-12-30
average_administered: [7.611111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 7.6 times with a 13.3 weekly interval (101.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3404.63
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-31
average_administered: [11.104166666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.1 times with a 2.3 weekly interval (25.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2145.29
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-29
average_administered: [14.627450980392156, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.6 times with a 10.9 weekly interval (159.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
labels: DIMETHYL FUMARATE
cost_pp_pa: 1781.71
first_seen: 2019-11-08T00:00:00
last_seen: 2025-11-10T00:00:00
first_seen_parent: 2019-11-08
last_seen_parent: 2025-12-01
average_administered: [22.666666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 22.7 times with a 14.1 weekly interval (321.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7295.34
first_seen: 2019-06-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-17
last_seen_parent: 2025-12-30
average_administered: [10.961538461538462, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 11.0 times with a 11.7 weekly interval (129.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4308.56
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-02T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-22
average_administered: [35.666666666666664, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 35.7 times with a 9.9 weekly interval (352.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 4479.85
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-30
average_administered: [29.08823529411765, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 29.1 times with a 4.9 weekly interval (141.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 4399.0
first_seen: 2024-04-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-31
average_administered: [8.282051282051283, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8.3 times with a 4.0 weekly interval (33.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2369.88
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [21.932773109243698, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21.9 times with a 9.4 weekly interval (206.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST
labels: APREMILAST
cost_pp_pa: 5983.38
first_seen: 2019-04-16T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-16
last_seen_parent: 2025-12-22
average_administered: [11.941176470588236, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 11.9 times with a 11.0 weekly interval (131.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3775.29
first_seen: 2019-06-06T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-11-27
average_administered: [11.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.0 times with a 9.0 weekly interval (99.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4203.19
first_seen: 2019-06-07T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-11-27
average_administered: [21.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 21.1 times with a 10.4 weekly interval (220.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 3202.41
first_seen: 2021-04-14T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2021-04-14
last_seen_parent: 2025-11-26
average_administered: [21.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 21.1 times with a 3.6 weekly interval (75.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3528.83
first_seen: 2024-01-07T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-01-07
last_seen_parent: 2025-12-23
average_administered: [5.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.2 times with a 5.0 weekly interval (26.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: RANIBIZUMAB
cost_pp_pa: 2957.94
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [13.043695380774032, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13.0 times with a 9.7 weekly interval (126.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2786.87
first_seen: 2021-05-04T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2021-05-04
last_seen_parent: 2025-12-23
average_administered: [13.817460317460318, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 13.8 times with a 13.9 weekly interval (191.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - IMMUNOGLOBULIN
labels: IMMUNOGLOBULIN
cost_pp_pa: 59778.39
first_seen: 2024-04-03T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-02
average_administered: [25.533333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 25.5 times with a 3.6 weekly interval (91.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
labels: INFLIXIMAB
cost_pp_pa: 2110.73
first_seen: 2024-04-12T00:00:00
last_seen: 2025-08-24T00:00:00
first_seen_parent: 2024-04-12
last_seen_parent: 2025-12-19
average_administered: [9.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: PAEDIATRIC GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - PAEDIATRIC GASTROENTEROLOGY

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - PAEDIATRIC GASTROENTEROLOGY - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9.5 times with a 8.1 weekly interval (77.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: AFLIBERCEPT
cost_pp_pa: 2724.89
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [14.749049429657795, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14.7 times with a 14.3 weekly interval (210.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: BEVACIZUMAB
cost_pp_pa: 1459.29
first_seen: 2021-02-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-02-05
last_seen_parent: 2025-12-31
average_administered: [4.266666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4.3 times with a 13.0 weekly interval (56.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: INFLIXIMAB
cost_pp_pa: 4294.03
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [17.92485549132948, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 17.9 times with a 6.4 weekly interval (115.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: UPADACITINIB
cost_pp_pa: 9783.96
first_seen: 2023-11-06T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2023-11-06
last_seen_parent: 2025-12-11
average_administered: [9.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 9.2 times with a 6.3 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: VEDOLIZUMAB
cost_pp_pa: 11406.79
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [29.73134328358209, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - VEDOLIZUMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 29.7 times with a 7.6 weekly interval (225.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
labels: DIMETHYL FUMARATE
cost_pp_pa: 2163.08
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [7.245098039215686, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 7.2 times with a 11.9 weekly interval (85.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4272.95
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-29
average_administered: [22.09090909090909, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 22.1 times with a 7.9 weekly interval (174.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 12984.81
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-05
last_seen_parent: 2025-12-29
average_administered: [26.166666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 26.2 times with a 7.4 weekly interval (195.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3053.05
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [10.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10.8 times with a 9.6 weekly interval (103.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4240.68
first_seen: 2022-09-01T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2022-03-02
last_seen_parent: 2025-11-26
average_administered: [12.333333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 12.3 times with a 7.9 weekly interval (97.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: TOCILIZUMAB
cost_pp_pa: 4734.39
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [10.0, 2.1666666666666665, 17.0, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB - TOCILIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.0 times with a 11.3 weekly interval (113.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 2.2 times with a 3.6 weekly interval (8.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 17.0 times with a 4.7 weekly interval (80.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 4565.21
first_seen: 2019-06-20T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-21
average_administered: [20.125, 14.625, 25.0, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 20.1 times with a 6.6 weekly interval (132.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 14.6 times with a 11.1 weekly interval (163.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 25.0 times with a 4.9 weekly interval (121.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 4742.13
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-20T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-20
average_administered: [28.625, 10.875, 16.375, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 28.6 times with a 7.9 weekly interval (225.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 10.9 times with a 11.6 weekly interval (126.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 16.4 times with a 6.9 weekly interval (112.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: RITUXIMAB
cost_pp_pa: 2414.79
first_seen: 2019-04-06T00:00:00
last_seen: 2025-10-16T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-09
average_administered: [7.2, 15.6, 4.8, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB - RITUXIMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.2 times with a 17.6 weekly interval (127.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 15.6 times with a 4.6 weekly interval (71.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4.8 times with a 19.1 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: SECUKINUMAB
cost_pp_pa: 4678.37
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-24
average_administered: [4.75, 16.75, 16.25, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4.8 times with a 40.1 weekly interval (193.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 16.8 times with a 1.9 weekly interval (31.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 16.2 times with a 10.6 weekly interval (171.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: USTEKINUMAB
cost_pp_pa: 6825.31
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-29
average_administered: [5.666666666666667, 8.555555555555555, 16.22222222222222, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB - USTEKINUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.7 times with a 3.9 weekly interval (22.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 8.6 times with a 9.9 weekly interval (85.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 16.2 times with a 10.3 weekly interval (167.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 3947.66
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-31
average_administered: [17.05263157894737, 10.421052631578947, 10.368421052631579, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 17.1 times with a 16.0 weekly interval (274.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 10.4 times with a 16.4 weekly interval (171.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 10.4 times with a 8.4 weekly interval (88.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: RITUXIMAB
cost_pp_pa: 2631.93
first_seen: 2019-04-17T00:00:00
last_seen: 2025-10-31T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-30
average_administered: [11.461538461538462, 7.6923076923076925, 3.3846153846153846, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT - RITUXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.5 times with a 7.1 weekly interval (82.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 7.7 times with a 4.6 weekly interval (35.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 3.4 times with a 8.4 weekly interval (29.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: INFLIXIMAB
cost_pp_pa: 3916.69
first_seen: 2020-12-01T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2020-02-21
last_seen_parent: 2025-12-29
average_administered: [3.5, 7.75, 10.75, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.5 times with a 6.0 weekly interval (21.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 7.8 times with a 5.4 weekly interval (42.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 10.8 times with a 6.7 weekly interval (73.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DIMETHYL FUMARATE
labels: ADALIMUMAB
cost_pp_pa: 1163.09
first_seen: 2019-06-30T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-06-30
last_seen_parent: 2025-12-23
average_administered: [12.0, 3.3333333333333335, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DIMETHYL FUMARATE|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DIMETHYL FUMARATE - ADALIMUMAB

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 12.0 times with a 2.1 weekly interval (26.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 3.3 times with a 55.9 weekly interval (184.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST
labels: ADALIMUMAB
cost_pp_pa: 5509.18
first_seen: 2019-12-05T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-10-04
last_seen_parent: 2025-12-23
average_administered: [9.75, 6.5, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: APREMILAST|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST - ADALIMUMAB

average_spacing:
<br><b>APREMILAST</b><br>On average given 9.8 times with a 4.6 weekly interval (45.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 6.5 times with a 10.7 weekly interval (70.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ETANERCEPT
cost_pp_pa: 4752.54
first_seen: 2020-01-08T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-09-20
last_seen_parent: 2025-11-27
average_administered: [4.5, 14.5, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.5 times with a 5.4 weekly interval (24.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 14.5 times with a 6.4 weekly interval (93.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: INFLIXIMAB
cost_pp_pa: 5144.36
first_seen: 2019-04-25T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-25
last_seen_parent: 2025-12-24
average_administered: [20.0, 23.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - VEDOLIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - VEDOLIZUMAB - INFLIXIMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 20.0 times with a 44.6 weekly interval (891.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 23.0 times with a 13.4 weekly interval (309.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: ADALIMUMAB
cost_pp_pa: 5112.74
first_seen: 2019-05-28T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-05-28
last_seen_parent: 2025-12-18
average_administered: [11.0, 13.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - CERTOLIZUMAB PEGOL

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - CERTOLIZUMAB PEGOL - ADALIMUMAB

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 11.0 times with a 8.9 weekly interval (97.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 13.0 times with a 5.3 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: AFLIBERCEPT
cost_pp_pa: 3537.5
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [15.936708860759493, 15.645569620253164, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 15.9 times with a 13.3 weekly interval (211.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 15.6 times with a 15.9 weekly interval (247.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: BEVACIZUMAB
cost_pp_pa: 2647.36
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-18
average_administered: [1.4545454545454546, 13.272727272727273, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - BEVACIZUMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 1.5 times with a 49.1 weekly interval (74.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 13.3 times with a 0.3 weekly interval (4.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: BEVACIZUMAB
cost_pp_pa: 1367.83
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-30
average_administered: [7.071428571428571, 2.7857142857142856, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 7.1 times with a 18.4 weekly interval (131.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 2.8 times with a 17.0 weekly interval (48.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 3182.18
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-24
average_administered: [14.238095238095237, 8.273809523809524, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14.2 times with a 11.4 weekly interval (162.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 8.3 times with a 7.0 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: INFLIXIMAB
cost_pp_pa: 3590.31
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-30
average_administered: [13.787878787878787, 19.363636363636363, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.8 times with a 7.6 weekly interval (104.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 19.4 times with a 6.7 weekly interval (130.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: INFLIXIMAB
cost_pp_pa: 2715.51
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [13.76, 16.8, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.8 times with a 9.0 weekly interval (124.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 16.8 times with a 6.3 weekly interval (106.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: UPADACITINIB
cost_pp_pa: 5014.55
first_seen: 2020-05-26T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2020-05-26
last_seen_parent: 2025-12-23
average_administered: [6.75, 7.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - UPADACITINIB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.8 times with a 5.1 weekly interval (35.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 7.5 times with a 9.0 weekly interval (68.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: UPADACITINIB
cost_pp_pa: 4657.5
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-22
average_administered: [14.333333333333334, 9.38888888888889, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.3 times with a 7.3 weekly interval (104.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 9.4 times with a 7.9 weekly interval (74.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: USTEKINUMAB
cost_pp_pa: 37133.13
first_seen: 2024-05-15T00:00:00
last_seen: 2025-07-25T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-31
average_administered: [6.0, 1.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.0 times with a 7.7 weekly interval (46.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 1.0 times with a 0.0 weekly interval (0.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: VEDOLIZUMAB
cost_pp_pa: 6359.76
first_seen: 2019-05-14T00:00:00
last_seen: 2025-12-04T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-04
average_administered: [12.5, 10.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - VEDOLIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.5 times with a 8.0 weekly interval (100.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10.5 times with a 5.3 weekly interval (56.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: ADALIMUMAB
cost_pp_pa: 3178.84
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-30
average_administered: [21.352941176470587, 8.235294117647058, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21.4 times with a 7.3 weekly interval (156.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 8.2 times with a 43.7 weekly interval (358.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: ADALIMUMAB
cost_pp_pa: 1800.98
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-29
average_administered: [18.5, 7.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB - ADALIMUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 18.5 times with a 6.1 weekly interval (114.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 7.5 times with a 34.0 weekly interval (255.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ADALIMUMAB
cost_pp_pa: 2862.45
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [19.73076923076923, 19.096153846153847, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19.7 times with a 13.3 weekly interval (262.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 19.1 times with a 25.7 weekly interval (491.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: IXEKIZUMAB
cost_pp_pa: 3965.76
first_seen: 2019-04-24T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-24
last_seen_parent: 2025-12-30
average_administered: [14.571428571428571, 13.285714285714286, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - IXEKIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.6 times with a 9.1 weekly interval (133.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 13.3 times with a 8.1 weekly interval (108.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2542.22
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-29
average_administered: [38.75, 9.625, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RANIBIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 38.8 times with a 8.1 weekly interval (316.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 9.6 times with a 7.7 weekly interval (74.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: RITUXIMAB
cost_pp_pa: 2389.8
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [11.735294117647058, 7.029411764705882, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.7 times with a 7.6 weekly interval (89.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 7.0 times with a 17.1 weekly interval (120.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: SECUKINUMAB
cost_pp_pa: 4738.71
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [9.64, 20.16, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.6 times with a 7.6 weekly interval (73.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 20.2 times with a 9.1 weekly interval (185.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: TOCILIZUMAB
cost_pp_pa: 4759.18
first_seen: 2021-06-12T00:00:00
last_seen: 2025-06-24T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-15
average_administered: [11.0, 16.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - TOCILIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.0 times with a 7.9 weekly interval (86.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 16.5 times with a 1.9 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: UPADACITINIB
cost_pp_pa: 3073.13
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-09
average_administered: [15.333333333333334, 12.833333333333334, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15.3 times with a 8.9 weekly interval (136.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 12.8 times with a 7.9 weekly interval (101.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: TOCILIZUMAB
cost_pp_pa: 4174.74
first_seen: 2019-04-11T00:00:00
last_seen: 2025-08-05T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-11-11
average_administered: [7.25, 52.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB - TOCILIZUMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.2 times with a 26.1 weekly interval (188.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 52.0 times with a 2.6 weekly interval (134.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: ABATACEPT
cost_pp_pa: 3569.01
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-30
average_administered: [24.75, 6.875, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|ABATACEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB - ABATACEPT

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24.8 times with a 25.6 weekly interval (634.0 weeks total treatment length)<br><b>ABATACEPT</b><br>On average given 6.9 times with a 24.7 weekly interval (171.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: RITUXIMAB
cost_pp_pa: 3518.8
first_seen: 2019-04-08T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-30
average_administered: [21.4, 4.1, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT - RITUXIMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 21.4 times with a 7.7 weekly interval (165.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4.1 times with a 15.9 weekly interval (65.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: SECUKINUMAB
cost_pp_pa: 6517.02
first_seen: 2019-04-24T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-24
last_seen_parent: 2025-12-29
average_administered: [7.285714285714286, 12.142857142857142, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.3 times with a 7.0 weekly interval (51.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 12.1 times with a 12.7 weekly interval (154.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 6503.69
first_seen: 2019-04-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-12-31
average_administered: [8.2, 6.4, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.2 times with a 6.3 weekly interval (52.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 6.4 times with a 12.0 weekly interval (77.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: ALIROCUMAB
cost_pp_pa: 1792.9
first_seen: 2019-08-14T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-08-14
last_seen_parent: 2025-12-22
average_administered: [12.0, 26.8, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY
drug_sequence: EVOLOCUMAB|ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY - EVOLOCUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY - EVOLOCUMAB - ALIROCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 12.0 times with a 39.4 weekly interval (473.0 weeks total treatment length)<br><b>ALIROCUMAB</b><br>On average given 26.8 times with a 5.9 weekly interval (157.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8598.88
first_seen: 2021-11-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-31
average_administered: [12.571428571428571, 2.7142857142857144, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.6 times with a 10.9 weekly interval (137.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 2.7 times with a 6.3 weekly interval (17.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 11809.02
first_seen: 2021-01-19T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2021-01-19
last_seen_parent: 2025-12-31
average_administered: [3.1666666666666665, 20.166666666666668, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.2 times with a 7.9 weekly interval (25.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 20.2 times with a 6.3 weekly interval (127.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: SECUKINUMAB
cost_pp_pa: 3757.78
first_seen: 2019-06-11T00:00:00
last_seen: 2025-09-03T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-18
average_administered: [17.0, 3.3333333333333335, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17.0 times with a 6.7 weekly interval (114.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 3.3 times with a 12.4 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ETANERCEPT
cost_pp_pa: 3377.89
first_seen: 2019-06-14T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-30
average_administered: [8.555555555555555, 12.11111111111111, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.6 times with a 8.1 weekly interval (70.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 12.1 times with a 7.4 weekly interval (90.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: RITUXIMAB
cost_pp_pa: 1373.44
first_seen: 2019-06-07T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-18
average_administered: [8.333333333333334, 7.333333333333333, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.3 times with a 8.3 weekly interval (69.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 7.3 times with a 16.9 weekly interval (123.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 6343.05
first_seen: 2019-06-25T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-21
average_administered: [7.230769230769231, 7.3076923076923075, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 7.2 times with a 6.6 weekly interval (47.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 7.3 times with a 10.9 weekly interval (79.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: RANIBIZUMAB
cost_pp_pa: 2338.41
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [14.764705882352942, 6.323529411764706, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14.8 times with a 10.0 weekly interval (148.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 6.3 times with a 8.0 weekly interval (50.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: DEXAMETHASONE
cost_pp_pa: 4134.27
first_seen: 2019-07-23T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-21
average_administered: [2.1, 9.7, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - DEXAMETHASONE

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.1 times with a 14.6 weekly interval (31.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 9.7 times with a 15.9 weekly interval (154.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 4027.97
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [9.359375, 14.734375, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9.4 times with a 15.3 weekly interval (144.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 14.7 times with a 11.0 weekly interval (162.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2464.07
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-29
average_administered: [9.071428571428571, 9.142857142857142, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9.1 times with a 5.3 weekly interval (48.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 9.1 times with a 10.6 weekly interval (96.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 2249.67
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-26
average_administered: [17.8, 31.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 17.8 times with a 20.0 weekly interval (356.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 31.0 times with a 35.3 weekly interval (1094.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: BEVACIZUMAB
cost_pp_pa: 2948.13
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [22.027027027027028, 16.54054054054054, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22.0 times with a 10.7 weekly interval (236.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 16.5 times with a 11.4 weekly interval (189.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: DEXAMETHASONE
cost_pp_pa: 2904.86
first_seen: 2019-06-13T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-06-13
last_seen_parent: 2025-12-30
average_administered: [17.375, 2.75, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - DEXAMETHASONE

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 17.4 times with a 9.4 weekly interval (164.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 2.8 times with a 21.7 weekly interval (61.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 4221.96
first_seen: 2019-06-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-30
average_administered: [21.168067226890756, 12.210084033613445, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.2 times with a 7.7 weekly interval (164.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 12.2 times with a 7.6 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2073.77
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-22
average_administered: [10.875, 13.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 10.9 times with a 27.7 weekly interval (302.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 13.5 times with a 22.3 weekly interval (301.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 2188.91
first_seen: 2019-05-03T00:00:00
last_seen: 2025-08-27T00:00:00
first_seen_parent: 2019-04-17
last_seen_parent: 2025-12-08
average_administered: [4.0, 18.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.0 times with a 69.3 weekly interval (277.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 18.0 times with a 5.1 weekly interval (93.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 1977.66
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-18
average_administered: [6.4375, 17.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.4 times with a 46.3 weekly interval (296.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 17.5 times with a 6.0 weekly interval (105.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - GOLIMUMAB
labels: GALCANEZUMAB
cost_pp_pa: 2445.27
first_seen: 2022-03-10T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2022-03-10
last_seen_parent: 2025-09-25
average_administered: [9.857142857142858, 5.857142857142857, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: GOLIMUMAB|GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - GOLIMUMAB - GALCANEZUMAB

average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 9.9 times with a 5.4 weekly interval (54.0 weeks total treatment length)<br><b>GALCANEZUMAB</b><br>On average given 5.9 times with a 46.9 weekly interval (276.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1334.6
first_seen: 2021-02-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2021-02-04
last_seen_parent: 2025-12-29
average_administered: [6.909090909090909, 4.2727272727272725, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.9 times with a 7.9 weekly interval (54.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4.3 times with a 7.3 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 3942.79
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-29
average_administered: [9.5, 20.333333333333332, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.5 times with a 7.3 weekly interval (69.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 20.3 times with a 6.9 weekly interval (139.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 2700.44
first_seen: 2019-05-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-02
last_seen_parent: 2025-12-31
average_administered: [9.428571428571429, 3.7142857142857144, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.4 times with a 7.1 weekly interval (67.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 3.7 times with a 9.0 weekly interval (33.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 3042.4
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-31
average_administered: [16.75, 3.625, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16.8 times with a 10.3 weekly interval (173.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 3.6 times with a 21.1 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2841.76
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [20.796178343949045, 6.10828025477707, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.8 times with a 10.0 weekly interval (208.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.1 times with a 5.0 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 4167.51
first_seen: 2021-03-08T00:00:00
last_seen: 2025-12-03T00:00:00
first_seen_parent: 2019-05-20
last_seen_parent: 2025-12-03
average_administered: [20.0, 2.3333333333333335, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.0 times with a 7.9 weekly interval (157.0 weeks total treatment length)<br><b>FREMANEZUMAB</b><br>On average given 2.3 times with a 8.3 weekly interval (19.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - GALCANEZUMAB
labels: GOLIMUMAB
cost_pp_pa: 2256.91
first_seen: 2022-01-11T00:00:00
last_seen: 2025-09-08T00:00:00
first_seen_parent: 2022-01-11
last_seen_parent: 2025-09-08
average_administered: [9.0, 3.75, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: GALCANEZUMAB|GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - GALCANEZUMAB - GOLIMUMAB

average_spacing:
<br><b>GALCANEZUMAB</b><br>On average given 9.0 times with a 22.0 weekly interval (198.0 weeks total treatment length)<br><b>GOLIMUMAB</b><br>On average given 3.8 times with a 6.4 weekly interval (24.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 2133.32
first_seen: 2023-04-20T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2023-04-20
last_seen_parent: 2025-12-15
average_administered: [3.5, 6.25, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.5 times with a 7.9 weekly interval (28.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 6.2 times with a 4.3 weekly interval (27.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: INFLIXIMAB
cost_pp_pa: 3902.67
first_seen: 2019-07-02T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-07-02
last_seen_parent: 2025-12-22
average_administered: [7.214285714285714, 17.571428571428573, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.2 times with a 10.6 weekly interval (76.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 17.6 times with a 5.9 weekly interval (103.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - CERTOLIZUMAB PEGOL
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - CERTOLIZUMAB PEGOL - IXEKIZUMAB
labels: IXEKIZUMAB
cost_pp_pa: 6914.66
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-04-05
last_seen_parent: 2025-12-08
average_administered: [22.2, 6.8, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 22.2 times with a 8.9 weekly interval (197.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 6.8 times with a 13.6 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - CERTOLIZUMAB PEGOL
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - CERTOLIZUMAB PEGOL - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 6576.15
first_seen: 2019-05-31T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2019-05-10
last_seen_parent: 2025-12-09
average_administered: [12.666666666666666, 18.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 12.7 times with a 5.6 weekly interval (71.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 18.0 times with a 5.7 weekly interval (103.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: USTEKINUMAB
cost_pp_pa: 4655.07
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-23
average_administered: [20.636363636363637, 7.909090909090909, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - USTEKINUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20.6 times with a 7.9 weekly interval (162.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 7.9 times with a 9.1 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: SECUKINUMAB
cost_pp_pa: 4039.81
first_seen: 2019-07-05T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2019-07-05
last_seen_parent: 2025-09-26
average_administered: [17.166666666666668, 6.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17.2 times with a 7.9 weekly interval (135.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 6.0 times with a 13.9 weekly interval (83.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 5265.76
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-31
average_administered: [12.666666666666666, 16.083333333333332, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.7 times with a 7.6 weekly interval (96.0 weeks total treatment length)<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 16.1 times with a 8.1 weekly interval (131.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ETANERCEPT
cost_pp_pa: 3178.6
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [10.653465346534654, 15.881188118811881, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.7 times with a 8.9 weekly interval (95.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 15.9 times with a 5.9 weekly interval (93.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: RANIBIZUMAB
cost_pp_pa: 2152.21
first_seen: 2020-04-03T00:00:00
last_seen: 2025-09-08T00:00:00
first_seen_parent: 2020-04-03
last_seen_parent: 2025-12-11
average_administered: [1.8571428571428572, 5.142857142857143, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB - RANIBIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.9 times with a 36.3 weekly interval (69.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 5.1 times with a 6.0 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: RANIBIZUMAB
cost_pp_pa: 2484.86
first_seen: 2019-04-22T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-23
average_administered: [19.375, 5.25, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 19.4 times with a 11.4 weekly interval (222.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 5.2 times with a 4.9 weekly interval (25.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: DEXAMETHASONE
cost_pp_pa: 2469.43
first_seen: 2019-05-22T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-04
last_seen_parent: 2025-12-31
average_administered: [3.3, 12.9, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - DEXAMETHASONE

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.3 times with a 55.1 weekly interval (182.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 12.9 times with a 10.3 weekly interval (133.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 3116.58
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [7.9504950495049505, 15.808580858085808, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.0 times with a 32.3 weekly interval (258.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 15.8 times with a 5.7 weekly interval (90.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: RITUXIMAB
cost_pp_pa: 1434.0
first_seen: 2020-09-09T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2020-09-09
last_seen_parent: 2025-12-23
average_administered: [5.666666666666667, 8.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - RITUXIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5.7 times with a 7.6 weekly interval (43.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 8.5 times with a 1.3 weekly interval (11.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 3613.92
first_seen: 2021-04-14T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2021-04-14
last_seen_parent: 2025-11-26
average_administered: [17.363636363636363, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 17.4 times with a 3.1 weekly interval (55.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3453.56
first_seen: 2025-06-04T00:00:00
last_seen: 2025-11-07T00:00:00
first_seen_parent: 2025-06-04
last_seen_parent: 2025-11-07
average_administered: [1.3333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 1.3 times with a 1.9 weekly interval (2.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2518.67
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-29
average_administered: [13.758620689655173, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.8 times with a 10.9 weekly interval (150.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7634.2
first_seen: 2019-09-18T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-09-18
last_seen_parent: 2025-12-29
average_administered: [10.415094339622641, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 10.4 times with a 8.9 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 12031.17
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-31
average_administered: [28.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 28.8 times with a 6.7 weekly interval (193.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 20574.06
first_seen: 2022-12-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-12-06
last_seen_parent: 2025-12-30
average_administered: [11.031746031746032, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 11.0 times with a 3.4 weekly interval (38.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 3349.32
first_seen: 2021-06-16T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-09-23
last_seen_parent: 2025-12-30
average_administered: [19.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 19.1 times with a 2.6 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 304.96
first_seen: 2024-08-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-08-02
last_seen_parent: 2025-12-29
average_administered: [7.916666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 7.9 times with a 2.0 weekly interval (16.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - OCTREOTIDE
labels: OCTREOTIDE
cost_pp_pa: 1500.7
first_seen: 2021-04-06T00:00:00
last_seen: 2025-12-10T00:00:00
first_seen_parent: 2021-04-06
last_seen_parent: 2025-12-10
average_administered: [4.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: OCTREOTIDE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OCTREOTIDE</b><br>On average given 4.8 times with a 16.1 weekly interval (77.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2312.88
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-31
average_administered: [11.585443037974683, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.6 times with a 10.0 weekly interval (116.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 4708.96
first_seen: 2019-05-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-05-17
last_seen_parent: 2025-12-30
average_administered: [19.916666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19.9 times with a 12.6 weekly interval (250.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4998.73
first_seen: 2019-06-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-10
last_seen_parent: 2025-12-31
average_administered: [7.690476190476191, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.7 times with a 11.9 weekly interval (91.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 937.87
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-31
average_administered: [1.8333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.8 times with a 9.7 weekly interval (17.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3008.77
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [10.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10.1 times with a 9.7 weekly interval (98.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3925.24
first_seen: 2022-12-23T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-12-23
last_seen_parent: 2025-12-29
average_administered: [8.035714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 8.0 times with a 9.1 weekly interval (73.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2796.9
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [16.808035714285715, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16.8 times with a 11.6 weekly interval (194.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 982.68
first_seen: 2021-03-16T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2021-03-16
last_seen_parent: 2025-12-18
average_administered: [2.9, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.9 times with a 19.0 weekly interval (55.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 2149.36
first_seen: 2019-08-05T00:00:00
last_seen: 2025-11-19T00:00:00
first_seen_parent: 2019-08-05
last_seen_parent: 2025-12-18
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 4.0 times with a 41.1 weekly interval (165.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4219.06
first_seen: 2023-11-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2023-11-03
last_seen_parent: 2025-12-31
average_administered: [5.932075471698113, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.9 times with a 6.0 weekly interval (35.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 5458.13
first_seen: 2019-04-16T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-16
last_seen_parent: 2025-12-31
average_administered: [37.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 37.0 times with a 6.3 weekly interval (233.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 7025.04
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [5.216216216216216, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5.2 times with a 6.0 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 23307.16
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-18
average_administered: [14.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 14.2 times with a 2.9 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8095.97
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-31
average_administered: [24.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24.2 times with a 12.3 weekly interval (297.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3337.33
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-30
average_administered: [40.55555555555556, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 40.6 times with a 6.9 weekly interval (278.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2394.84
first_seen: 2022-12-05T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-12-05
last_seen_parent: 2025-12-29
average_administered: [5.8076923076923075, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.8 times with a 10.1 weekly interval (59.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 4646.94
first_seen: 2019-05-02T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-05-02
last_seen_parent: 2025-12-23
average_administered: [25.666666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25.7 times with a 10.0 weekly interval (257.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 8330.85
first_seen: 2019-07-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-07-01
last_seen_parent: 2025-12-29
average_administered: [17.636363636363637, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 17.6 times with a 12.6 weekly interval (221.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 8784.42
first_seen: 2019-04-08T00:00:00
last_seen: 2025-11-03T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-11-03
average_administered: [63.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 63.2 times with a 4.9 weekly interval (307.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - RILUZOLE
labels: RILUZOLE
cost_pp_pa: 374.35
first_seen: 2020-01-03T00:00:00
last_seen: 2025-09-30T00:00:00
first_seen_parent: 2020-01-03
last_seen_parent: 2025-09-30
average_administered: [3.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY
drug_sequence: RILUZOLE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RILUZOLE</b><br>On average given 3.4 times with a 9.1 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 4020.03
first_seen: 2019-04-17T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-31
average_administered: [12.162790697674419, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.2 times with a 9.0 weekly interval (110.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4378.04
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [23.216867469879517, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 23.2 times with a 6.0 weekly interval (139.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 13083.67
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [21.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 21.0 times with a 6.6 weekly interval (138.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 7860.88
first_seen: 2024-10-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-10-29
last_seen_parent: 2025-12-31
average_administered: [10.555555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 10.6 times with a 2.0 weekly interval (21.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1609.45
first_seen: 2024-07-29T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-29
average_administered: [5.30188679245283, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 5.3 times with a 2.4 weekly interval (13.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2657.36
first_seen: 2021-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-02-12
last_seen_parent: 2025-12-30
average_administered: [16.68421052631579, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 16.7 times with a 9.0 weekly interval (150.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - GALCANEZUMAB
labels: GALCANEZUMAB
cost_pp_pa: 2852.96
first_seen: 2022-01-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2022-01-17
last_seen_parent: 2025-12-31
average_administered: [16.785714285714285, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY
drug_sequence: GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GALCANEZUMAB</b><br>On average given 16.8 times with a 8.1 weekly interval (137.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - IMMUNOGLOBULIN
labels: IMMUNOGLOBULIN
cost_pp_pa: 80369.1
first_seen: 2024-04-05T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2024-04-05
last_seen_parent: 2025-12-15
average_administered: [33.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 33.2 times with a 2.3 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORTH WEST ANGLIA NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - NORTH WEST ANGLIA NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: N/A
first_seen: 2025-04-10T00:00:00
last_seen: 2025-11-19T00:00:00
first_seen_parent: 2023-11-23
last_seen_parent: 2025-11-28
average_administered: [1.3333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORTH WEST ANGLIA NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.3 times with a 0.0 weekly interval (0.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORTH WEST ANGLIA NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - NORTH WEST ANGLIA NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3539.02
first_seen: 2020-10-21T00:00:00
last_seen: 2025-10-28T00:00:00
first_seen_parent: 2020-10-21
last_seen_parent: 2025-10-30
average_administered: [14.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORTH WEST ANGLIA NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14.0 times with a 10.7 weekly interval (150.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 8313.29
first_seen: 2019-11-08T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-11-08
last_seen_parent: 2025-12-18
average_administered: [14.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 14.4 times with a 9.7 weekly interval (140.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8034.48
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-29
average_administered: [23.152173913043477, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23.2 times with a 12.9 weekly interval (298.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 4916.51
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-31
average_administered: [7.676470588235294, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.7 times with a 3.1 weekly interval (24.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3097.51
first_seen: 2020-01-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-12-31
average_administered: [10.01086956521739, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.0 times with a 9.3 weekly interval (93.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 2769.06
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [32.9875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 33.0 times with a 7.6 weekly interval (250.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1879.06
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [8.60655737704918, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8.6 times with a 26.7 weekly interval (230.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 5719.44
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-29
average_administered: [29.02857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 29.0 times with a 8.9 weekly interval (257.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 8380.64
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [47.85454545454545, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 47.9 times with a 5.1 weekly interval (246.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2076.04
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [27.72502210433245, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27.7 times with a 8.6 weekly interval (237.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 4712.43
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [20.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20.0 times with a 12.4 weekly interval (249.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 8431.78
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [23.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 23.9 times with a 10.0 weekly interval (239.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3635.32
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [36.263565891472865, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 36.3 times with a 8.6 weekly interval (311.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - FILGOTINIB
labels: FILGOTINIB
cost_pp_pa: 6273.1
first_seen: 2023-01-18T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2022-09-06
last_seen_parent: 2025-12-30
average_administered: [8.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 8.0 times with a 4.3 weekly interval (34.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - GOLIMUMAB
labels: GOLIMUMAB
cost_pp_pa: 8326.71
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [34.142857142857146, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 34.1 times with a 9.4 weekly interval (322.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: IMMUNOGLOBULIN
cost_pp_pa: 37774.88
first_seen: 2024-04-04T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2021-04-23
last_seen_parent: 2025-12-11
average_administered: [16.88235294117647, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 16.9 times with a 2.4 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1513.76
first_seen: 2024-11-26T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-11-26
last_seen_parent: 2025-12-31
average_administered: [3.9285714285714284, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: BREAST SURGERY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.9 times with a 2.6 weekly interval (10.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY - ACALABRUTINIB
labels: ACALABRUTINIB
cost_pp_pa: 29403.99
first_seen: 2024-05-01T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-05-01
last_seen_parent: 2025-12-19
average_administered: [12.714285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 12.7 times with a 5.0 weekly interval (64.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY - IMMUNOGLOBULIN
labels: IMMUNOGLOBULIN
cost_pp_pa: 33990.94
first_seen: 2024-04-19T00:00:00
last_seen: 2025-08-08T00:00:00
first_seen_parent: 2024-04-19
last_seen_parent: 2025-08-08
average_administered: [20.833333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 20.8 times with a 2.3 weekly interval (48.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2410.15
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [20.17241379310345, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 20.2 times with a 9.4 weekly interval (190.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST
labels: APREMILAST
cost_pp_pa: 5746.69
first_seen: 2019-04-16T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-16
last_seen_parent: 2025-12-22
average_administered: [11.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 11.8 times with a 11.6 weekly interval (137.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7313.88
first_seen: 2019-06-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-17
last_seen_parent: 2025-12-30
average_administered: [10.975903614457831, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 11.0 times with a 11.4 weekly interval (126.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: TOFACITINIB
cost_pp_pa: 4439.0
first_seen: 2019-12-30T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-12-30
last_seen_parent: 2025-12-24
average_administered: [29.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - TOFACITINIB

average_spacing:
<br><b>TOFACITINIB</b><br>On average given 29.8 times with a 8.1 weekly interval (243.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: USTEKINUMAB
cost_pp_pa: 57328.79
first_seen: 2024-04-08T00:00:00
last_seen: 2025-03-13T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [6.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 6.0 times with a 9.7 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: VEDOLIZUMAB
cost_pp_pa: 11300.25
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [28.616438356164384, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - VEDOLIZUMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 28.6 times with a 7.6 weekly interval (217.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
labels: DIMETHYL FUMARATE
cost_pp_pa: 2215.33
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [6.964912280701754, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 7.0 times with a 11.9 weekly interval (83.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2777.17
first_seen: 2021-05-04T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2021-05-04
last_seen_parent: 2025-12-23
average_administered: [13.604477611940299, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 13.6 times with a 14.1 weekly interval (192.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - IMMUNOGLOBULIN
labels: IMMUNOGLOBULIN
cost_pp_pa: 58099.24
first_seen: 2024-04-03T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-02
average_administered: [17.345454545454544, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 17.3 times with a 3.1 weekly interval (54.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
labels: INFLIXIMAB
cost_pp_pa: 2306.83
first_seen: 2024-04-12T00:00:00
last_seen: 2025-08-24T00:00:00
first_seen_parent: 2024-04-12
last_seen_parent: 2025-12-19
average_administered: [8.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: PAEDIATRIC GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - PAEDIATRIC GASTROENTEROLOGY

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - PAEDIATRIC GASTROENTEROLOGY - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8.7 times with a 7.6 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: ADALIMUMAB
cost_pp_pa: 2863.07
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [30.810126582278482, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30.8 times with a 8.3 weekly interval (255.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: INFLIXIMAB
cost_pp_pa: 4346.97
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [17.028720626631852, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 17.0 times with a 6.3 weekly interval (107.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: AFLIBERCEPT
cost_pp_pa: 2688.59
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [13.860273972602739, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13.9 times with a 14.1 weekly interval (197.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: BEVACIZUMAB
cost_pp_pa: 1085.45
first_seen: 2020-05-21T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-23
last_seen_parent: 2025-12-31
average_administered: [3.76, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 3.8 times with a 12.9 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: DEXAMETHASONE
cost_pp_pa: 3588.62
first_seen: 2023-02-13T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2022-11-07
last_seen_parent: 2025-12-31
average_administered: [2.6666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE

average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.7 times with a 22.7 weekly interval (61.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3613.06
first_seen: 2024-01-07T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-01-07
last_seen_parent: 2025-12-23
average_administered: [4.777777777777778, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.8 times with a 4.4 weekly interval (21.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: RANIBIZUMAB
cost_pp_pa: 2552.26
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [11.976303317535544, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 12.0 times with a 10.6 weekly interval (127.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: ACALABRUTINIB
cost_pp_pa: 30115.89
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-29
average_administered: [18.055555555555557, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 18.1 times with a 4.3 weekly interval (78.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: DOCETAXEL
cost_pp_pa: 1178.09
first_seen: 2025-01-13T00:00:00
last_seen: 2025-10-15T00:00:00
first_seen_parent: 2025-01-13
last_seen_parent: 2025-10-15
average_administered: [3.1666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - DOCETAXEL

average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.2 times with a 2.4 weekly interval (8.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: IMMUNOGLOBULIN
cost_pp_pa: 21326.02
first_seen: 2024-04-05T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2024-04-05
last_seen_parent: 2025-09-26
average_administered: [18.914285714285715, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 18.9 times with a 2.4 weekly interval (46.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: OBINUTUZUMAB
cost_pp_pa: 34211.06
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-31
average_administered: [8.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: OBINUTUZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - OBINUTUZUMAB

average_spacing:
<br><b>OBINUTUZUMAB</b><br>On average given 8.3 times with a 2.6 weekly interval (21.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY - OCTREOTIDE
labels: OCTREOTIDE
cost_pp_pa: 6387.56
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-11
average_administered: [10.833333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ENDOCRINOLOGY
drug_sequence: OCTREOTIDE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OCTREOTIDE</b><br>On average given 10.8 times with a 4.1 weekly interval (45.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 4214.15
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-30
average_administered: [27.25531914893617, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 27.3 times with a 5.3 weekly interval (144.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 8742.82
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [16.318181818181817, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16.3 times with a 12.4 weekly interval (203.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 6830.27
first_seen: 2024-11-28T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2024-11-28
last_seen_parent: 2025-12-09
average_administered: [4.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 4.8 times with a 4.9 weekly interval (23.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3717.42
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-31
average_administered: [28.55263157894737, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28.6 times with a 8.9 weekly interval (253.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 5105.03
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-31
average_administered: [16.77181208053691, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 16.8 times with a 6.1 weekly interval (103.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 8370.45
first_seen: 2023-05-24T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-31
average_administered: [2.0344827586206895, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.0 times with a 18.4 weekly interval (37.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5099.34
first_seen: 2023-03-14T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2023-03-14
last_seen_parent: 2025-12-30
average_administered: [5.638297872340425, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.6 times with a 6.3 weekly interval (35.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 3511.7
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [8.644736842105264, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.6 times with a 10.4 weekly interval (90.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 3267.62
first_seen: 2023-03-10T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2023-01-24
last_seen_parent: 2025-09-26
average_administered: [4.555555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 4.6 times with a 16.3 weekly interval (75.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY
labels: ALIROCUMAB
cost_pp_pa: 2244.17
first_seen: 2021-01-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-01-11
last_seen_parent: 2025-12-30
average_administered: [15.15, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY
drug_sequence: ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY - ALIROCUMAB

average_spacing:
<br><b>ALIROCUMAB</b><br>On average given 15.2 times with a 7.0 weekly interval (106.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY
labels: EVOLOCUMAB
cost_pp_pa: 1903.86
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [46.28333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY - EVOLOCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 46.3 times with a 4.9 weekly interval (225.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3340.96
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [21.784688995215312, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.8 times with a 11.6 weekly interval (252.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1625.75
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [13.87378640776699, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 13.9 times with a 10.1 weekly interval (141.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2068.51
first_seen: 2019-06-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-08
last_seen_parent: 2025-12-31
average_administered: [13.673469387755102, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13.7 times with a 17.6 weekly interval (241.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 8921.87
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-31
average_administered: [157.0625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 157.1 times with a 2.7 weekly interval (426.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - CERTOLIZUMAB PEGOL
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 7782.19
first_seen: 2019-07-12T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-24
average_administered: [36.72222222222222, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 36.7 times with a 8.7 weekly interval (320.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3760.06
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-31
average_administered: [30.342105263157894, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30.3 times with a 8.3 weekly interval (251.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - FILGOTINIB
labels: FILGOTINIB
cost_pp_pa: 3180.85
first_seen: 2021-12-10T00:00:00
last_seen: 2025-09-21T00:00:00
first_seen_parent: 2021-10-25
last_seen_parent: 2025-12-22
average_administered: [8.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 8.0 times with a 20.7 weekly interval (166.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - GOLIMUMAB
labels: GOLIMUMAB
cost_pp_pa: 8093.44
first_seen: 2019-06-05T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-09-26
average_administered: [48.76923076923077, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 48.8 times with a 6.4 weekly interval (314.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: RITUXIMAB
cost_pp_pa: 5744.06
first_seen: 2020-08-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-08-06
last_seen_parent: 2025-12-31
average_administered: [11.092436974789916, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.1 times with a 2.7 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3517.92
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-31
average_administered: [11.08433734939759, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.1 times with a 2.0 weekly interval (22.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 129503.1
first_seen: 2025-02-12T00:00:00
last_seen: 2025-08-18T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-08-18
average_administered: [3.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 3.0 times with a 0.0 weekly interval (0.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3602.0
first_seen: 2019-06-06T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-11-27
average_administered: [11.181818181818182, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.2 times with a 13.0 weekly interval (146.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4108.95
first_seen: 2022-09-01T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2022-03-02
last_seen_parent: 2025-11-26
average_administered: [11.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11.5 times with a 8.4 weekly interval (97.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8372.39
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-24
average_administered: [26.36842105263158, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 26.4 times with a 12.4 weekly interval (328.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY - EVOLOCUMAB
labels: EVOLOCUMAB
cost_pp_pa: 1799.88
first_seen: 2019-06-11T00:00:00
last_seen: 2025-09-08T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-10-29
average_administered: [21.22222222222222, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ENDOCRINOLOGY
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 21.2 times with a 8.3 weekly interval (176.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4044.82
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-29
average_administered: [22.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 22.2 times with a 7.3 weekly interval (162.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2047.24
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-31
average_administered: [14.833333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14.8 times with a 14.4 weekly interval (214.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 3519.42
first_seen: 2025-05-19T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-30
average_administered: [2.6363636363636362, 2.727272727272727, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.6 times with a 4.1 weekly interval (11.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 2.7 times with a 3.0 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 2158.37
first_seen: 2025-02-17T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-23
average_administered: [1.6428571428571428, 3.642857142857143, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 1.6 times with a 8.0 weekly interval (13.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 3.6 times with a 1.0 weekly interval (4.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3719.37
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-31
average_administered: [10.461538461538462, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10.5 times with a 1.6 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 5353.43
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-31
average_administered: [4.555555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.6 times with a 4.4 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1195.9
first_seen: 2025-02-17T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-23
average_administered: [3.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.9 times with a 9.9 weekly interval (38.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 12122.38
first_seen: 2025-02-28T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-28
last_seen_parent: 2025-12-29
average_administered: [3.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 3.8 times with a 4.6 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1265.16
first_seen: 2025-03-12T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-12
last_seen_parent: 2025-12-29
average_administered: [2.4411764705882355, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.4 times with a 11.6 weekly interval (28.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1784.81
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-30
average_administered: [3.098159509202454, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.1 times with a 5.3 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1576.97
first_seen: 2025-05-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-04-09
last_seen_parent: 2025-12-30
average_administered: [2.3181818181818183, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.3 times with a 4.7 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 27678.3
first_seen: 2025-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-04-02
last_seen_parent: 2025-12-31
average_administered: [1.1666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.2 times with a 3.0 weekly interval (4.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6212.11
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-30
average_administered: [3.4642857142857144, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 3.5 times with a 5.1 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1193.18
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-19
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.0 times with a 5.1 weekly interval (10.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 11455.51
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-30
average_administered: [1.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 1.8 times with a 3.0 weekly interval (5.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 3445.18
first_seen: 2025-05-12T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-05-12
last_seen_parent: 2025-12-18
average_administered: [7.285714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 7.3 times with a 2.7 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 23055.96
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-30
average_administered: [6.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 6.5 times with a 3.3 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: ACALABRUTINIB
cost_pp_pa: 52439.45
first_seen: 2025-03-13T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2025-03-13
last_seen_parent: 2025-12-15
average_administered: [4.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 4.8 times with a 3.0 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 7228.36
first_seen: 2025-07-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-07-07
last_seen_parent: 2025-12-29
average_administered: [1.3571428571428572, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 1.4 times with a 1.4 weekly interval (2.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: RITUXIMAB
cost_pp_pa: 5130.45
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-31
average_administered: [9.18348623853211, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9.2 times with a 1.4 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: OBINUTUZUMAB
cost_pp_pa: 38945.83
first_seen: 2025-04-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-27
last_seen_parent: 2025-12-31
average_administered: [8.583333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: OBINUTUZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - OBINUTUZUMAB

average_spacing:
<br><b>OBINUTUZUMAB</b><br>On average given 8.6 times with a 2.1 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: IMMUNOGLOBULIN
cost_pp_pa: 18843.12
first_seen: 2025-03-03T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-09-25
average_administered: [6.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 6.0 times with a 2.1 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 13031.28
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-18
average_administered: [2.409090909090909, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 2.4 times with a 8.6 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2285.84
first_seen: 2025-02-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-13
last_seen_parent: 2025-12-30
average_administered: [3.5714285714285716, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 3.6 times with a 7.3 weekly interval (26.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 6307.45
first_seen: 2025-03-28T00:00:00
last_seen: 2025-11-19T00:00:00
first_seen_parent: 2025-03-28
last_seen_parent: 2025-11-19
average_administered: [4.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 4.9 times with a 3.6 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 18116.48
first_seen: 2025-03-11T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2025-03-11
last_seen_parent: 2025-11-20
average_administered: [2.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 2.4 times with a 8.6 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: INFLIXIMAB
cost_pp_pa: 6178.12
first_seen: 2025-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-30
average_administered: [4.6239316239316235, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.6 times with a 3.6 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2300.68
first_seen: 2025-06-16T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-04-04
last_seen_parent: 2025-12-29
average_administered: [3.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.0 times with a 9.0 weekly interval (27.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1626.38
first_seen: 2025-04-17T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2025-04-17
last_seen_parent: 2025-11-25
average_administered: [2.1818181818181817, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.2 times with a 6.0 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 12655.04
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-29
average_administered: [6.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 6.2 times with a 3.4 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2850.0
first_seen: 2025-02-25T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-02-25
last_seen_parent: 2025-12-24
average_administered: [2.2222222222222223, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.2 times with a 6.7 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3003.5
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-24
average_administered: [3.5555555555555554, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.6 times with a 4.3 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - FILGOTINIB
labels: FILGOTINIB
cost_pp_pa: 3864.05
first_seen: 2025-03-17T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2025-03-17
last_seen_parent: 2025-12-22
average_administered: [4.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 4.2 times with a 2.6 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 5555.86
first_seen: 2025-03-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-04
last_seen_parent: 2025-12-30
average_administered: [4.6923076923076925, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4.7 times with a 3.4 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 14498.61
first_seen: 2025-03-17T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2025-03-17
last_seen_parent: 2025-11-25
average_administered: [2.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 2.4 times with a 7.6 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1990.39
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-30
average_administered: [5.666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.7 times with a 6.7 weekly interval (38.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 9140.87
first_seen: 2025-08-15T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-08-15
last_seen_parent: 2025-12-23
average_administered: [1.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 1.8 times with a 3.0 weekly interval (5.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: RANIBIZUMAB
cost_pp_pa: 2674.42
first_seen: 2025-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-23
average_administered: [2.6869565217391305, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.7 times with a 4.0 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: VEDOLIZUMAB
cost_pp_pa: 28191.52
first_seen: 2025-07-31T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-07-31
last_seen_parent: 2025-12-31
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 3.5 times with a 4.1 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: BEVACIZUMAB
cost_pp_pa: 527.46
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-31
average_administered: [1.5789473684210527, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.6 times with a 7.6 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: AFLIBERCEPT
cost_pp_pa: 7697.7
first_seen: 2025-02-17T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-02
average_administered: [3.2745098039215685, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.3 times with a 4.6 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 4139.8
first_seen: 2025-03-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-10
last_seen_parent: 2025-12-31
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.0 times with a 3.4 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1798.79
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-19
average_administered: [4.043478260869565, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.0 times with a 5.6 weekly interval (22.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 22126.35
first_seen: 2025-06-30T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-06-30
last_seen_parent: 2025-12-18
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 5.0 times with a 3.6 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 25799.11
first_seen: 2025-06-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-06-04
last_seen_parent: 2025-12-31
average_administered: [4.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 4.8 times with a 4.9 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8432.11
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-30
average_administered: [3.6666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 3.7 times with a 6.0 weekly interval (22.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 10230.94
first_seen: 2025-04-25T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-30
average_administered: [4.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.1 times with a 3.9 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 4345.68
first_seen: 2025-02-28T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-28
last_seen_parent: 2025-12-31
average_administered: [3.619047619047619, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.6 times with a 4.0 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 18475.15
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-31
average_administered: [1.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 1.6 times with a 2.1 weekly interval (3.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 5215.74
first_seen: 2025-03-17T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2025-03-17
last_seen_parent: 2025-11-20
average_administered: [2.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 2.8 times with a 10.9 weekly interval (30.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 7943.15
first_seen: 2025-02-27T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-27
last_seen_parent: 2025-12-31
average_administered: [9.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 9.0 times with a 2.6 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1338.87
first_seen: 2025-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-04-02
last_seen_parent: 2025-12-29
average_administered: [4.173913043478261, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.2 times with a 2.7 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6719.5
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-31
average_administered: [4.239726027397261, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.2 times with a 4.1 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 3001.3
first_seen: 2025-09-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-09-29
last_seen_parent: 2025-12-31
average_administered: [1.896551724137931, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 1.9 times with a 2.3 weekly interval (4.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4829.83
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-31
average_administered: [4.048387096774194, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.0 times with a 6.0 weekly interval (24.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1055.11
first_seen: 2025-03-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-07
last_seen_parent: 2025-12-30
average_administered: [2.4444444444444446, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.4 times with a 10.7 weekly interval (26.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2037.96
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-30
average_administered: [2.6493506493506493, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.6 times with a 7.6 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 6716.83
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-17
average_administered: [3.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 3.0 times with a 10.4 weekly interval (31.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2839.27
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-01T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-01
average_administered: [2.6666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.7 times with a 5.9 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6695.86
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-29
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 3.5 times with a 6.0 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 5624.66
first_seen: 2025-03-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-04
last_seen_parent: 2025-12-31
average_administered: [3.3333333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.3 times with a 6.3 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1821.75
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-30
average_administered: [2.9717514124293785, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.0 times with a 5.1 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 5362.85
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-31
average_administered: [4.545454545454546, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.5 times with a 4.4 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 34279.58
first_seen: 2025-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-14
last_seen_parent: 2025-12-31
average_administered: [1.1764705882352942, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.2 times with a 2.3 weekly interval (3.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1547.39
first_seen: 2025-02-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-30
average_administered: [2.161290322580645, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.2 times with a 3.9 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 11511.64
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-30
average_administered: [1.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 1.8 times with a 3.1 weekly interval (6.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 7029.24
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-17
average_administered: [2.6666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 2.7 times with a 8.7 weekly interval (24.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2062.92
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-30
average_administered: [2.5875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.6 times with a 7.3 weekly interval (19.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3948.63
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-01T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-01
average_administered: [2.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.4 times with a 4.3 weekly interval (10.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 5724.95
first_seen: 2025-03-19T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-19
last_seen_parent: 2025-12-29
average_administered: [2.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 2.4 times with a 2.9 weekly interval (7.0 weeks total treatment length)


